US20020077596A1 - Perfusion shunt apparatus and method - Google Patents
Perfusion shunt apparatus and method Download PDFInfo
- Publication number
- US20020077596A1 US20020077596A1 US10/077,312 US7731202A US2002077596A1 US 20020077596 A1 US20020077596 A1 US 20020077596A1 US 7731202 A US7731202 A US 7731202A US 2002077596 A1 US2002077596 A1 US 2002077596A1
- Authority
- US
- United States
- Prior art keywords
- diverter
- aortic
- aorta
- expandable conduit
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/011—Instruments for their placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/018—Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0008—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0019—Angular shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0065—Three-dimensional shapes toroidal, e.g. ring-shaped, doughnut-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/008—Quadric-shaped paraboloidal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
Definitions
- the present invention relates generally to aortic diverters for temporary or permanent placement in the aorta in order to divert embolic material away from the arteries that carry blood to the brain, i.e., the carotid or cerebral arteries (including the brachiocephalic trunk, the left common carotid, and the left subclavian; ANNE R. AGUR, GRANT'S ATLAS OF ANATOMY 52 (9th ed., Williams & Wilkins 1991) (1943) (this and all other references cited herein are expressly incorporated by reference as if set forth in their entirety in this disclosure)).
- the invention relates to aortic diverters placed within the ascending aorta, either temporarily or permanently, such that embolic debris entering the aorta are carried through or past the diverter and past the carotid arteries, thus being diverted away from cerebral blood vessels.
- the present invention also relates to methods of protecting patients against cerebral embolization by using aortic diverters.
- emboli in the aorta come from several sources.
- aortic atheroma which detaches from the wall of the aorta due to various reasons including incising, clamping, and/or clamp release of the aorta during surgery (see, Barbut et al., “Cerebral Emboli Detected During Bypass Surgery Are Associated With Clamp Removal,” Stroke, 25(12):2398-2402 (1994)); 2) thrombus which forms in the right atrium resulting from atrial fibrillation; 3) thrombus which forms on ventricular assist devices; 4) venous thrombus which passes into the left ventricle through a patent foramen ovale or other arteriovenous shunt; and 6) other less common sources.
- implantable vena cava filters reduce the incidence of pulmonary embolism, but they only trap large emboli, and they have a tendency to become clogged as they accumulate material.
- Cottenceau et al. U.S. Pat. No. 5,375,612 discloses a blood filter intended for implantation in a blood vessel, typically in the vena cava.
- This device comprises a zigzagged thread wound on itself and a central strainer section to retain blood clots.
- Another example is Lefebvre, French Patent No. 2,567,405, which discloses a blood filter for implantation by an endovenous route into the vena cava.
- the filtering means may consist of a flexible metallic grid, a flexible synthetic or plastic grid, a weave of synthetic filaments, or a non-degradable or possibly biodegradable textile cloth.
- a filter that functions in arteries must address additional concerns because of the hemodynamic differences between arteries and veins. Arteries are much more flexible and elastic than veins and, in the arteries, blood flow is pulsatile with large pressure variations between systolic and diastolic flow. These pressure variations cause the artery walls to expand and contract. Thus, filters and diverters must be able to expand and contract along with the lumen of the aorta to which they may be anchored.
- the present invention relates to aortic diverters and methods of diverting or redirecting emboli away from the carotid arteries to prevent cerebral embolization.
- the invention includes safe aortic diverters positionable in the ascending aorta in order to divert embolic material of all sizes away from the carotid arteries, thereby washing emboli downstream into the thoracic and peripheral vasculature.
- the devices of the present invention are adapted to be placed in the ascending and transverse aorta in order to divert embolic material away from the carotid arteries.
- This embolic matter includes but is not limited to atheromatous fragments or material, thrombus, globules of fat, air bubbles, clumps of bacteria and/or other foreign matter, tumor cells, or any other bits of tissue.
- the aortic diverters of the present invention can be placed surgically, endoscopically or percutaneously, and either permanently or temporarily.
- the aortic diverter includes two components.
- the first component is a hollow tube, which is substantially cylindrical, conical or frustoconical in shape.
- the hollow tube is an appropriate size to fit within the lumen of the ascending aorta.
- the proximal end of the hollow tube is adapted to fill the lumen of the aorta so that substantially all blood entering the ascending aorta from the heart must travel through the hollow tube in order to continue past the ascending aorta and into the other arteries leading to the rest of the human body.
- the second component is an anchoring mechanism for securing the hollow tube to the lumen of the aorta.
- the aortic diverter also includes two components.
- the first component is a hollow tube, which is substantially cylindrical, conical or frustoconical in shape.
- the hollow tube is an appropriate size to fit within the lumen of the ascending aorta.
- the proximal end of the hollow tube is adapted to fill the lumen of the aorta so that substantially all blood entering the ascending aorta from the heart must travel through the hollow tube in order to continue past the ascending aorta and into the other arteries leading to the rest of the human body.
- the second component is a sleeve secured to the proximal end of the hollow tube.
- the sleeve can be substantially rigid and circumferentially sized to frictionally anchor the hollow tube to the lumen of the aorta.
- the aortic diverter is a flat, planar, snowshoe device that can be placed across the apex of the aorta in order to prevent emboli from flowing into the carotid arteries.
- the snowshoe diverter comprises a planar tongue and a handle, and can also include supports or legs mounted on either or both sides of the tongue.
- the handle is attached to the proximal end of the tongue for convenient connection to an introducing device such as a cannula, and is also useful for easy orientation and placement of the snowshoe diverter within the aorta.
- the handle itself can be hollow, thus acting as a cannula to supply filtered blood to the carotid arteries as well as the descending aorta.
- the hollow cannulated handle can be attached to the tongue such that blood flowing out of the handle and into the aorta is partitioned by the tongue to flow either anterior or posterior the tongue.
- the cannulated handle can be attached to the tongue so that all blood flowing out of the handle and into the aorta flows anterior the tongue.
- the cannulated handle can be attached to the tongue so that all blood flowing out of the handle and into the aorta flows posterior the tongue.
- the handle can be solid with no lumen for blood flow.
- the handle can also be flexible and bendable in order to move the handle out of the way of the surgeon.
- the tongue of the snowshoe diverter has a compliant framework that allows conformance with naturally irregular interval wall structures within the aorta.
- the framework allows the size of the tongue to be reduced allowing for introduction through small incisions, thus minimizing aortic trauma.
- the tongue can be rolled or folded up in any direction or manner.
- the framework can comprise rings that are circular or oval.
- the framework can be a figure-eight suspension frame.
- the tongue also has a thin, compliant membrane that is impermeable to emboli.
- the membrane can be made of a mesh material that may be cotton based, Teflon, nitinol, urethane or polyurethane, any combination of the above, or a combination of the above along with wire.
- the tongue can be made of material that is impermeable to blood, but have one or more way valves allowing unidirectional blood flow.
- the tongue can be flexible and/or elastomeric, thus enabling the tongue to be rolled or folded up in any direction or manner.
- the tongue can be amoeba-shaped, curved or billowed, tapered, or a combination thereof.
- the methods of the present invention relate to the prevention of cerebral embolization.
- Cerebral embolization can occur when emboli found in the bloodstream are carried to the brain and become lodged in the smaller blood vessels of the brain, thus obstructing blood flow to an area of the brain, which can result in a stroke.
- One way of protecting patients against cerebral embolization is by preventing emboli from reaching the smaller blood vessels in the brain.
- an aortic diverter is provided.
- the aortic diverter is inserted into the aortic arch in the region of the carotid arteries.
- the surgeon secures the aortic diverter to the lumen of the aorta so that the proximal end of the aortic diverter extends upstream of the brachiocephalic trunk while the distal end of the aortic diverter extends downstream of the left subclavian artery.
- the carotid arteries directly connected to the aortic arch are just the left and right branch of the brachiocephalic trunk (see ANNE R.
- the distal end of the aortic diverter extends downstream of the left brachiocephalic trunk.
- emboli entering the ascending aorta will necessarily have to flow through the aortic diverter and exit the distal end of the aortic diverter downstream of the carotid arteries, thus reducing the likelihood that emboli will reach the openings leading into the carotid arteries.
- the surgeon provides an aortic diverter comprising a planar filter material which is impermeable to emboli but not to blood.
- the surgeon inserts the filter material into the aortic arch in the region of the carotid arteries.
- the surgeon secures the filter material to the aortic lumen so that it completely covers all of the openings leading from the aorta into the carotid arteries such that blood flowing into the carotid arteries is filtered of embolic material.
- the embolic material is not trapped on the filter but is washed downstream of the left subclavian artery or the left brachiocephalic trunk by the stream of blood rushing through the aorta into the peripheral vasculature.
- the surgeon provides an aortic cannula.
- the surgeon then penetrates the wall of the aorta with the aortic cannula, which can have an inflatable balloon occluder concentrically disposed on its distal end.
- the aortic cannula is sutured to the wall of the aorta to prevent loss of blood.
- the balloon occluder can be inflated to prevent back-flow of blood towards the region of the heart.
- the surgeon then provides the snowshoe diverter previously described.
- the surgeon then inserts the snowshoe diverter through the aortic cannula and into the aortic arch in the region of the carotid arteries, thus preventing emboli from flowing into the carotid arteries.
- the snowshoe diverter can be integral with the aortic cannula and disposed on the distal end of the aortic cannula.
- the surgeon then provides a blood-return cannula. If the handle of the snowshoe diverter is hollow (i.e., cannulated), the surgeon can connect the blood-return cannula to the handle of the snowshoe diverter such that it is in fluid communication with the handle. If the handle of the snowshoe diverter is not hollow, then the surgeon can connect the blood-return cannula to the aortic cannula such that it is in fluid communication with the aortic cannula.
- the surgeon can insert the blood-return cannula through the wall of the aorta either upstream or downstream of the point of insertion of the aortic cannula.
- the surgeon removes the snowshoe diverter from the aorta.
- an aortic cannula with a snowshoe aortic diverter attached to its distal end is introduced.
- the aortic cannula is inserted through the wall of the aorta and the snowshoe diverter is positioned in the region of the carotid arteries.
- the aortic cannula can be inserted through the wall of the aorta while the snowshoe diverter fully deployed.
- the snowshoe diverter can be hidden inside the lumen of the aortic cannula until after the aortic cannula is inserted through the wall of the aorta.
- the snowshoe diverter can then be deployed and positioned over the carotid arteries.
- the snowshoe diverter extends over all of the openings leading into the carotid arteries.
- the aortic cannula is sutured to the wall of the aorta to prevent loss of blood.
- a cardioplegia cannula comprising an opening in its distal end is then introduced.
- the cardioplegia cannula also has an inflatable balloon occluder concentrically mounted around its distal end. The cardioplegia cannula is inserted through the wall of the aorta and sutured to the wall of the aorta to prevent loss of blood.
- the balloon occluder is inflated to prevent all fluid flow downstream thereof, and then cardioplegia solution is delivered to the heart through the opening in the distal end of the cardioplegia cannula.
- Blood from a bypass machine is introduced into the aorta through aortic cannula. Blood flowing out of the distal end of the cannula and into the aorta can be partitioned by the snowshoe diverter such that some of the blood flows to the carotid arteries superior to the snowshoe diverter while the rest of the blood flows anterior the snowshoe diverter and toward the descending aorta and peripheral vasculature.
- the snowshoe device can be attached to the distal end of the aortic cannula in such a way as to divert substantially all blood exiting the distal end of the cannula to either the carotid arteries or the peripheral vasculature.
- an aortic diverter which is a substantially cylindrical, conical or frustoconical hollow tube comprising a wall that is impermeable to emboli.
- the hollow tube is substantially flexible, is in a compressed state, and is releasably carried by an intravascular catheter for percutaneous delivery into the aorta.
- the hollow tube allows blood to flow through the tube, and the proximal end of the hollow tube is circumferentially sized to completely fill the lumen of the aorta.
- the surgeon introduces the intravascular catheter containing the compressed aortic diverter into the vascular system.
- the surgeon advances the intravascular catheter into the aortic arch to the region of the carotid arteries.
- the surgeon deploys the aortic diverter so that the aortic diverter radially expands to contact the lumen of the aorta.
- the proximal end of the aortic diverter should completely fill the lumen of the aorta and should extend upstream of the brachiocephalic trunk.
- the distal end of the aortic diverter should extend downstream of the left subclavian artery (or the left brachiocephalic trunk in those patients having this as the most downstream carotid artery) so that when emboli exit the distal end of the aortic diverter, they are downstream of the carotid arteries, thus reducing the likelihood that they will reach the openings leading into the carotid arteries.
- the surgeon secures the aortic diverter to the lumen of the aorta, either by friction of contact or by other means discussed herein.
- the present invention addresses the dangers associated with cerebral embolization. Specifically, embolization contributes significantly to problems such as stroke, lengthy hospital stays, and, in some cases, death.
- Embolic material which has been detected at 2.88 mm in diameter, will generally range from 0.02 mm (20 ⁇ m) to 5 mm, and consists predominantly of atheromatous fragments dislodged from the aortic wall and air bubbles introduced during dissection, but also includes platelet aggregates which form during cardiac surgery, thrombus in general, globules of fat, clumps of bacteria and/or other foreign matter, tumor cells, or any other bits of tissue. These emboli enter either the cerebral circulation or systemic arterial system. Those entering the cerebral circulation obstruct small arteries and lead to macroscopic or microscopic cerebral infarction, with ensuing neurocognitive dysfunction.
- the present invention is intended to divert emboli away from the carotid arteries, which direct blood to the brain. This diversion prevents strokes, which can lead to lengthy hospital stays, damage to the brain, and sometimes death.
- the present invention is particularly suited for those who are at high risk of suffering from cerebral embolization, such as elderly patients and those who have atheromatosis, as well as those patients undergoing cardiac surgery, which has been shown to result in the release of emboli into the bloodstream. See, for example, Barbut et al., “Cerebral Emboli Detected During Bypass Surgery Are Associated With Clamp Removal,” Stroke, 25(12):2398-2402 (1994).
- one object is to provide safe and reliable devices that are easy to manufacture and use.
- a further object is to provide devices that may be used in the aorta, and especially in the ascending aorta.
- Yet another object is to provide devices that will reduce the likelihood of cerebral embolization, especially in those patients who are at high risk for cerebral embolization.
- Yet another object is to provide devices that can be introduced into the aorta and secured to the lumen of the aorta with minimal trauma to the patient.
- the devices disclosed herein have the following characteristics: they can withstand high arterial blood flow rates for an extended time; they can expand and contract with the wall of the aorta; they can be made of a monolithic molded material that is impermeable to blood as well as emboli, such as Teflon impregnated with an anti-thrombogenic coating or nitinol impregnated with an anti-thrombogenic coating, or they can be made of material that is impermeable to emboli and not blood, such as a mesh, a woven material, or a thin polymer; they can be biodegradable; they can include openings on their walls of any shape or predetermined pattern, wherein the openings are covered in material that is impermeable to emboli; they can be introduced surgically, endoscopically, or percutaneously with cannulas or intravascular catheters introduced through the femoral artery, subclavian artery, brachiocephalic artery, or a cut-down to the abdominal aor
- an object is to prevent cerebral embolization.
- the methods of this invention can be employed on various patients, especially those at high risk for cerebral embolization, in order to reduce the incidence of cerebral embolization, which can lead to neurologic or cognitive complications and death.
- Another object is to temporarily or permanently divert emboli away from the carotid arteries by forcing emboli downstream of the openings leading from the aorta into the carotid arteries.
- Another object is to provide a method for eliminating or minimizing cerebral embolization during invasive cardiac procedures.
- Yet another object is to provide a method of introducing an aortic diverter intravascularly or with a cannula for minimal trauma to the patient.
- FIG. 1 is a longitudinal view of an aorta diverter according to one embodiment, showing the aortic diverter positioned within the ascending aorta.
- FIG. 2 is a longitudinal view of an aortic diverter according to another embodiment, and in which the aortic diverter is positioned within the ascending aorta and is made of a material that is permeable to blood but impermeable to emboli.
- FIG. 3 is a longitudinal view of an aortic diverter according to another embodiment, and in which the aortic diverter is positioned within the ascending aorta and is made of a material that is impermeable to blood, wherein the aortic diverter has openings on its surface, and wherein the openings are covered with material that is permeable to blood but impermeable to emboli.
- FIG. 4 is a three-dimensional drawing of an aortic diverter according to another embodiment, showing the aortic diverter positioned across the openings leading into the carotid arteries, and in which the aortic diverter is permeable to blood but impermeable to emboli.
- FIG. 5 is a longitudinal view of a temporary aortic diverter, wherein a cannula penetrating the lumen of the ascending aorta is used to hold the aortic diverter in position during surgery, and wherein a cardioplegia cannula with a balloon occluder is used to deliver cardioplegia solution to the heart.
- FIG. 6 is a longitudinal view of an intravascular catheter with associated self-expanding aortic diverter and removable actuation sleeve.
- FIG. 7 is a cross-sectional view through section line 7 - 7 of the device depicted in FIG. 6.
- FIG. 8 is a longitudinal view of the device depicted in FIG. 7 positioned within the ascending aorta, wherein the actuation sleeve is shown being removed to release the self-expanding aortic diverter, and the aortic diverter is shown in a self-expanding state.
- FIG. 9 is a longitudinal view of the device depicted in FIG. 8 positioned within the ascending aorta, wherein the catheter is being removed and the aortic diverter is in a fully expanded and operable state within the ascending aorta.
- FIG. 10 is a cross-sectional view through section line 10 - 10 of the aortic diverter as it is art. percutaneously delivered to the ascending aorta.
- FIG. 11 is a longitudinal view of a cannula penetrating the lumen of the ascending aorta, wherein an aortic diverter is disposed within the cannula.
- FIG. 12 is a longitudinal view of the device depicted in FIG. 11, wherein the self-expanding aortic diverter is pushed through the cannula and is expanding as it exits the cannula.
- FIG. 13 is a longitudinal view of the device depicted in FIG. 11, wherein the aortic diverter is in a fully expanded and operable state within the ascending aorta.
- FIG. 14 is a longitudinal view of a snowshoe aortic diverter as it is inserted through the aortic cannula and into position in the aorta, wherein the blood-return cannula is in fluid communication with the aortic cannula.
- FIG. 14A is a detail of the tongue of the snowshoe diverter of FIG. 14.
- FIG. 14B is a cross-sectional view through section B-B of the snowshoe aortic diverter depicted in FIG. 14.
- FIG. 15 is a three-dimensional view of a tongue of a snowshoe aortic diverter, wherein the tongue is flat and has supports.
- FIG. 15A is a threedimensional view of a tongue of a snowshoe aortic diverter, wherein the tongue is curved or billowed.
- FIG. 15B is a three-dimensional view of a tongue of a snowshoe aortic diverter, wherein the tongue is tapered in that the proximal end of the tongue is wider than the distal end thereof.
- FIG. 15C is a three-dimensional view of a tongue of a snowshoe aortic diverter, wherein the tongue is tapered in that the proximal end of the tongue is narrower than the distal end thereof.
- FIG. 16 is a longitudinal view of a snowshoe aortic diverter positioned to prevent emboli from entering the carotid arteries, wherein a blood-return cannula is inserted through the wall of the aorta in order to allow blood into the aorta.
- FIG. 17 is a longitudinal view of a snowshoe aortic diverter, wherein the snowshoe aortic diverter is directly connected to the distal end of an aortic cannula, wherein a blood-return cannula is in fluid communication with the aortic cannula, and wherein blood entering the aorta is directed either towards the carotid arteries or posterior to the snowshoe diverter.
- FIG. 18 is a longitudinal view of a snowshoe diverter inserted upstream from a blood-return cannula and wherein blood returning to the peripheral vasculature must first pass through the snowshoe diverter.
- FIG. 19 is a longitudinal view of a snowshoe aortic diverter after it has been positioned in the region of the carotid arteries above an aortic cannula with a inflatable balloon occluder, wherein the aortic cannula allows blood to flow into the aorta, and wherein the snowshoe diverter prevents emboli from entering the carotid arteries.
- FIG. 20 is a longitudinal view of a snowshoe aortic diverter attached to the distal end of an aortic cannula with an inflatable balloon occluder, wherein blood flowing out of the distal end of the aortic cannula is diverted to flow either into the carotid arteries or anterior the snowshoe diverter and into the peripheral vasculature.
- FIG. 21 is a top view of a tapered snowshoe aortic diverter with a ring suspension frame.
- FIG. 21A is a cross-sectional view through section A-A of the snowshoe aortic diverter depicted in FIG. 21.
- FIG. 22 is a top view of a curved or billowed snowshoe aortic diverter with a ring suspension frame.
- FIG. 22A is a cross-sectional view through section A-A of the snowshoe aortic diverter depicted in FIG. 22.
- FIG. 23 is a top view of a flat snowshoe aortic diverter with supports and a ring suspension frame.
- FIG. 23A is a cross-section view through section A-A of the snowshoe aortic diverter depicted in FIG. 23.
- FIG. 24 is a top view of a flat snowshoe aortic diverter with a one-way valve.
- FIG. 24A is a cross-sectional view through section A-A of the snowshoe aortic diverter depicted in FIG. 24.
- FIG. 25 is a top view of a flat snowshoe aortic diverter with a one-way valve and a ring suspension frame.
- FIG. 25A is a cross-sectional view through section A-A of the snowshoe aortic diverter depicted in FIG. 25.
- FIG. 26 is a top view of a flat snowshoe aortic diverter with a FIG. 8 suspension frame.
- FIG. 1 shows one embodiment of the aortic diverter 10 for use herein.
- the aortic diverter 10 is a hollow tube 20 with an anchoring mechanism 50 in connection with the proximal end 30 of the hollow tube 20 .
- the hollow tube 20 comprises a substantially cylindrical or conical wall 25 , which is impermeable to blood.
- the wall 25 of the hollow tube 20 can be made of a monolithic molded material. This material can be urethane, Teflon or nitinol, any of which may be impregnated with an anti-thrombogenic coating. However, other materials that are impermeable to blood can also be used, including materials that are biodegradable.
- the hollow tube 20 has a proximal end 30 terminating in a substantially circular edge adapted to fill the lumen of the aorta or the anchoring mechanism 50 .
- the hollow tube also has a distal end 40 . Both the proximal end 30 and distal end 40 of the hollow tube 20 are substantially open.
- an anchoring mechanism 50 for securing the aortic diverter 10 to the lumen of the aorta.
- the anchoring mechanism 50 can be a sleeve adapted to frictionally engage the lumen of the aorta or any one of the following: one or more sutures, one or more clips, one or more hooks, or adhesive material.
- the anchoring mechanism 50 may simply comprise the proximal end 30 of the hollow tube 20 itself, which may be adapted to frictionally engage the lumen of the aorta.
- the proximal end 30 of the hollow tube 20 may be substantially rigid, thus making it capable of being lodged into the lumen of the aorta.
- the hollow tube 20 can be substantially rigid or a flexible windsock. Furthermore, where the hollow tube 20 is a flexible windsock, the proximal end 30 may still be substantially rigid for frictional engagement with the lumen of the aorta.
- the aortic diverter 10 depicted in FIG. 1 prevents emboli from reaching the carotid arteries because it prevents lateral blood flow to the carotid arteries. Blood reaches the carotid arteries due to back-flow over the distal end 40 of the aortic diverter 10 . Atherembolic material continue downstream because they are less susceptible to being swept retrograde due to their greater density over blood.
- FIG. 2 shows the aortic diverter 10 with a wall 25 that is made of a material that is permeable to blood but impermeable to emboli.
- the wall 25 can be made of a mesh material, a woven material, a thin polymer, or any material that is permeable to blood but impermeable to emboli, including material that is biodegradable.
- the wall 25 of the hollow tube 20 can be impermeable to blood, but have openings 70 that are covered with material 80 that is permeable to blood yet impermeable to emboli.
- the distal end of the aortic diverter 10 may also be adapted to completely fill the lumen of the aorta such that there is no backflow of blood to the carotid arteries. There is no need for backflow because blood flows to the carotid arteries laterally through the wall 25 of FIG. 2 or the openings 70 of FIG. 3.
- the aortic diverter 10 prevent emboli from reaching the carotid arteries because emboli cannot laterally pass through the wall 25 of FIG. 2, or alternatively the openings 70 of FIG. 3. Furthermore, the danger of backflow carrying emboli to the carotid arteries is reduced because the pressure caused by lateral blood flow through the wall 25 of FIG. 2, or alternatively the openings 70 of FIG. 3, counteracts with the backflow pressure, reducing the amount of blood that reaches the carotid arteries due to backflow. Moreover, when the distal end 40 of the aortic diverter 10 is adapted to fill the lumen of the aorta, there is no backflow to the carotid arteries. In either case, emboli are washed downstream and into the peripheral vasculature without ever reaching the carotid arteries.
- the openings 70 can be of any shape including circles, ovals, rectangles, octagons, squares, or slits.
- the wall 25 of the hollow tube 20 may include one opening 70 or a plurality of openings 70 .
- the openings 70 can be radially disposed along the circumference of the hollow tube 20 or longitudinally disposed along the length of the hollow tube 20 .
- the openings can be one or more continuous rings disposed along the circumference of the hollow tube 20 , or one or more continuous columns longitudinally disposed along the length of the hollow tube 20 .
- the substantially rigid proximal end 30 may be lodged into the lumen of the aorta by surgically placing the proximal end 30 at a point where the proximal end 30 has a larger circumference than the lumen of the aorta.
- the hollow tube 20 can be introduced into the aorta in a compressed, but rigidly expandable state, either percutaneously or surgically. The hollow tube 20 can then be allowed to self-expand or forced to radially expand into frictional engagement with the lumen of the aorta.
- FIGS. 6 through 10 show one method of introducing and positioning aortic diverter 10 in the ascending aorta.
- FIGS. 6 through 10 show aortic diverter 10 , which is self-expanding, loaded onto assembly 90 for percutaneous delivery.
- the intravascular catheter 110 operates over a standard guidewire 100 .
- Aortic diverter 10 expands between a compressed state and a radially expanded state.
- FIGS. 6 and 7 show aortic diverter 10 contained in a compressed state by generally inelastic sleeve 130 , which surrounds diverter 10 and prevents it from self-expanding.
- FIG. 8 shows the intravascular catheter assembly 90 positioned in the ascending aorta.
- the sleeve 130 is pulled back, thus allowing aortic diverter 10 to deploy.
- diverter 10 is released, and intravascular catheter 110 is pulled back along the guidewire and removed.
- the proximal end 30 of the aortic diverter 10 completely fills the lumen of the aorta so that substantially all blood flowing into the ascending aorta must pass through the aortic diverter 10 .
- FIG. 10 is a cross sectional view through line 10 - 10 of FIG.
- FIGS. 11 through 13 show another method of delivering the aortic diverter 10 to the ascending aorta. In this method, the aortic diverter 10 is again self-expanding, but is delivered with a cannula 140 that directly penetrates the lumen of the aorta.
- FIG. 11 shows the cannula 140 , after having penetrated the aorta, with the aortic diverter 10 contained within the barrel of the cannula 140 .
- FIG. 12 shows the aortic diverter 10 emerging from the outlet 150 of the cannula 140 and self-expanding since it is no longer contained in a compressed state.
- FIG. 13 shows the aortic diverter 10 completely deployed and operable.
- the proximal end 10 of the aortic diverter 10 completely fills the lumen of the aorta such that substantially all blood flowing into the aorta from the heart must flow through the aortic diverter 10 .
- the distal end 40 of the aortic diverter 10 may also completely fill the lumen of the aorta if the wall 25 of the aortic diverter 10 is permeable to blood but impermeable to emboli as in FIGS. 2 and 3.
- FIG. 4 shows another embodiment of an aortic diverter 85 comprising a substantially planar filter material which is permeable to blood but impermeable to emboli.
- the aortic diverter 85 can be anchored to the lumen of the aorta with one of the following: one or more sutures, clips, hooks, or adhesive material.
- the aortic diverter 85 prevents emboli from entering the carotid arteries.
- emboli are blocked and are swept downstream with the current of blood.
- the aortic diverter 85 can be substantially rigid or flexible and surgically, endoscopically, or percutaneously delivered to the aorta. Percutaneous delivery can be accomplished using an intravascular catheter assembly 90 as in FIG. 6 and constructing the aortic diverter 85 so that it is self-expanding and concentrically mountable around the intravascular catheter 110 . Once deployed, the aortic diverter 85 can be secured to the lumen of the aorta with various anchoring mechanisms disclosed in the preceding paragraph.
- Surgical delivery of the aortic diverter 85 can be accomplished using a method similar to the one depicted in FIGS. 11 - 13 .
- the aortic diverter 85 can be compressibly disposed within the barrel of the cannula 140 and constructed to self-expand when no longer constrained by the walls of the cannula 140 .
- the aortic diverter 85 can be secured to the lumen of the aorta with the various anchoring mechanisms previously disclosed.
- Procedures such as incising, clamping, clamp release, and balloon occluding, which are applied during cardiopulmonary bypass, are known to cause embolization.
- the aorta is clamped or balloon-occluded. Because clamping and/or balloon occluding the aorta dislodges atheromatous material from the walls of the aorta, which is released into the bloodstream, an aortic diverter is needed before clamping and/or balloon occluding begins in order to divert embolic material away from the carotid arteries. Atheromatous material also accumulates behind clamps during surgery and, because removal of the clamps releases this material into the bloodstream, an aortic diverter must be maintained within the bloodstream for about four to ten minutes after removal of the clamps.
- FIG. 5 shows a “snowshoe” aortic diverter 200 attached to the distal end of a cannula for temporary diversion of embolic material away from the carotid arteries during cardiopulmonary bypass.
- the method for diverting emboli away from the carotid arteries will be described in connection with the “snowshoe” aortic diverter 200 depicted in FIG. 5.
- the cannula 205 with aortic diverter 200 attached to the distal end 210 of the cannula 205 is introduced into an incision made in the aorta.
- the aortic diverter 200 may be inside the cannula and advanced through the distal end 210 of the cannula 205 after the cannula 205 is introduced into the incision made in the aorta.
- the aortic diverter 200 is positioned in the aorta, extending over all of the openings leading to the carotid arteries, in order to ensure that emboli do not reach the brain.
- the cannula 205 is sutured to the aortic wall. Then a cardioplegia cannula 230 with a balloon occluder 250 attached to its distal end 245 is introduced into another incision made in the aorta.
- the cardioplegia cannula 230 is sutured to the aortic wall.
- the balloon occluder 250 is inflated in order to block all fluid flow downstream thereof, and the cardioplegia cannula 230 then delivers cardioplegic solution through an opening 240 in its distal end into the heart, thereby causing the heart to be paralyzed.
- Balloon occluding may inadvertently dislodge atheromatous material from the walls of the aorta and release it into the bloodstream.
- the aortic diverter 200 prevents the atheromatous material from entering the carotid arteries. Blood from a bypass machine is introduced into the aorta through the cannula 210 . Once surgery is complete, bypass is discontinued, and the balloon occluder is deflated, thereby releasing more atheromatous material.
- the aortic diverter 200 is left in position for four to ten minutes and then removed.
- FIG. 14 depicts another implementation of snowshoe diverter 200 deployed within aorta 306 .
- Cannula 205 includes side channel 301 for receiving filtered blood from a bypass machine (not shown). The blood travels through cannula 205 , and is split into a first stream 302 (blood supply for carotid arteries) and a second stream 303 (blood supply for descending aorta) as it passes from blood supply channel 305 (FIG. 14B).
- Cannula 205 therefore delivers oxygenated blood to the aorta above and below diverter 200 , so that the stream of blood is split.
- FIG. 14A is an expanded longitudinal view of diverter 200 with handle 304
- FIG. 14B shows a cross-section taken through section lines 14 B in FIG. 14, and showing diverter 200 and blood supply channels 305 .
- FIGS. 15 - 15 C show various configurations for the diverting member 200 .
- FIG. 15 shows amoeba-shaped tongue diverter 200 having external wire supports 308 attached.
- FIG. 15A shows curved tongue diverter 200 , which may, in some embodiments include wire supports (not shown).
- a diverter in the shape of a tapered tongue is depicted in FIGS. 15B and 15C.
- the diverter tongue may be comprised of a mesh (free of polyurethane), a mesh-polyurethane composite, or a mesh-polyurethane-wire composite.
- the diverter tongue may be constructed with or without wire supports.
- cannula 205 is used to deploy diverter 200 in aorta 306 , while separate cannula 307 delivers oxygenated blood to the aorta.
- Diverter 200 is porous for this implementation, thus permitting blood to enter cerebral circulation by passing through diverter 200 .
- the diverter tongue may be deployed above the aortic cannula (FIG. 16), below the aortic cannula (FIG. 18), or midway with respect to the aortic cannula (FIG. 17).
- the diverter may be integral with the cannula, separately insertable through the cannula, or inserted through a separate stick in the aorta.
- the diverter may be part of an aortic occluder in certain embodiments (FIGS. 19 and 20).
- Balloon occluder 311 is circumferentially disposed about cannula 205 , and diverter 200 is deployed therethrough (FIG. 20).
- a top-mounted diverter structure is shown in FIG. 19, but it will be understood that a bottom-mounted structure would also be advantageous, and would deliver blood above the diverter.
- Cannula 205 optionally includes flange 310 to ensure proper placement and positioning through aorta 306 .
- FIG. 21 shows a tapered tongue diverter 200 having suspension ring 315 mounted therein.
- FIG. 21A depicts an end view of the diverter of FIG. 21.
- Suspension ring 315 is a collapsible force biasing element which holds frame 317 in an open position when not compressed. Ring 315 is collapsible to permit loading and delivery through a standard cannula.
- FIG. 22 shows a snowshoe diverter with a curved or billowed membrane (see FIG. 22A cross-section), mesh, valve, or combination thereof.
- FIG. 23 shows a diverter having a plurality of legs 316 , or external wire supports.
- diverter 200 includes a flap valve formed by overlap of edges 320 of diverter 200 (see FIG. 24A cross-section).
- the flap valve allows blood to flow in one direction (see FIG. 24B).
- FIG. 24B a snowshoe is particularly useful for deployment below the blood cannula
- Each flap of the diverter is formed of a nonporous membrane, filter mesh material, combination membrane and filter, one way flap valve, or flap valve with filter.
- This same design can be implemented with suspension ring 315 (see FIG. 25), multiple suspension rings (not shown), or a figure-eight suspension frame (see FIG. 26).
Abstract
A catheter apparatus for use in a body passage. The catheter comprises a catheter shaft and an expandable conduit defined by a filter mesh material of varying porosity mounted on said catheter shaft. The expandable conduit has an upstream end and a downstream end, the expandable conduit having a collapsed position in which the expandable conduit is collapsed toward the catheter shaft and an expanded position in which the upstream end of the expandable conduit is open to fluid flow. The expandable conduit has an upstream sealing member at the upstream end of the expandable conduit for creating a seal between the upstream end of the expandable conduit and an internal wall of the body passage.
Description
- This is a continuation of U.S. application Ser. No. 09/642,570, filed Aug. 17, 2000, which is a continuation of U.S. application Ser. No. 08/996,532, filed Dec. 23, 1997, now U.S. Pat. No. 6,258,120. This is also a continuation-in-part of U.S. application Ser. No. 09/016,714, filed Jan. 30, 1998, which is a continuation-in-part of U.S. application Ser. No. 08/854,806, filed May 12, 1997, now U.S. Pat. No. 6,231,544. This is also a continuation-in-part of U.S. application Ser. No. 09/467,293, filed Dec. 17, 1999, which is a continuation of U.S. application Ser. No. 09/387,634, filed Aug. 31, 1999, now U.S. Pat. No. 6,176,851, which is a continuation of U.S. application Ser. No. 08/993,202, filed Dec. 18, 1997, now U.S. Pat. No. 6,048,331, which is a continuation-in-part of U.S. application Ser. No. 08/854,806, filed May 12, 1997, now U.S. Pat. No. 6,231,544. All of the above patents and applications are expressly incorporated herein by reference in their entirety.
- The present invention relates generally to aortic diverters for temporary or permanent placement in the aorta in order to divert embolic material away from the arteries that carry blood to the brain, i.e., the carotid or cerebral arteries (including the brachiocephalic trunk, the left common carotid, and the left subclavian; ANNE R. AGUR, GRANT'S ATLAS OF ANATOMY 52 (9th ed., Williams & Wilkins 1991) (1943) (this and all other references cited herein are expressly incorporated by reference as if set forth in their entirety in this disclosure)). More particularly, the invention relates to aortic diverters placed within the ascending aorta, either temporarily or permanently, such that embolic debris entering the aorta are carried through or past the diverter and past the carotid arteries, thus being diverted away from cerebral blood vessels. The present invention also relates to methods of protecting patients against cerebral embolization by using aortic diverters.
- Preventing emboli from entering the carotid arteries (i.e., the brachiocephalic, the left common carotid, and the left subclavian) by way of the aorta reduces the incidence of ischemic stroke. Emboli in the aorta come from several sources. These sources include: 1) aortic atheroma which detaches from the wall of the aorta due to various reasons including incising, clamping, and/or clamp release of the aorta during surgery (see, Barbut et al., “Cerebral Emboli Detected During Bypass Surgery Are Associated With Clamp Removal,”Stroke, 25(12):2398-2402 (1994)); 2) thrombus which forms in the right atrium resulting from atrial fibrillation; 3) thrombus which forms on ventricular assist devices; 4) venous thrombus which passes into the left ventricle through a patent foramen ovale or other arteriovenous shunt; and 6) other less common sources.
- There are a number of known devices designed to filter blood (see, e.g., Barbut et al., International Application No. PCT/US97/12751, and Barbut et al., U.S. Pat. No.5,662,671), but no known devices designed to divert or redirect emboli past the carotid arteries. Using careful surgical techniques, the chance of an embolic event causing harm to the patient by way of cerebral embolization is so low that emboli managing devices have not been considered. Thus, there are no known solutions to minimizing the probability of cerebral embolization, except for reducing the amount of emboli released into the blood stream by careful handling of blood vessels.
- On the venous side of the circulatory system, implantable vena cava filters reduce the incidence of pulmonary embolism, but they only trap large emboli, and they have a tendency to become clogged as they accumulate material. For example, Cottenceau et al., U.S. Pat. No. 5,375,612 discloses a blood filter intended for implantation in a blood vessel, typically in the vena cava. This device comprises a zigzagged thread wound on itself and a central strainer section to retain blood clots. Another example is Lefebvre, French Patent No. 2,567,405, which discloses a blood filter for implantation by an endovenous route into the vena cava. The filtering means may consist of a flexible metallic grid, a flexible synthetic or plastic grid, a weave of synthetic filaments, or a non-degradable or possibly biodegradable textile cloth.
- There are very few intravascular devices designed for arterial and especially aortic filtration, much less diversion. A filter that functions in arteries must address additional concerns because of the hemodynamic differences between arteries and veins. Arteries are much more flexible and elastic than veins and, in the arteries, blood flow is pulsatile with large pressure variations between systolic and diastolic flow. These pressure variations cause the artery walls to expand and contract. Thus, filters and diverters must be able to expand and contract along with the lumen of the aorta to which they may be anchored.
- The problem of preventing emboli from reaching the cerebral vasculature has thus far not been adequately addressed. Therefore, a need exists for new devices and methods to prevent embolic material from entering the carotid/cerebral arteries, while maintaining peripheral blood flow from the heart to the descending aorta.
- The present invention relates to aortic diverters and methods of diverting or redirecting emboli away from the carotid arteries to prevent cerebral embolization. The invention includes safe aortic diverters positionable in the ascending aorta in order to divert embolic material of all sizes away from the carotid arteries, thereby washing emboli downstream into the thoracic and peripheral vasculature. The devices of the present invention are adapted to be placed in the ascending and transverse aorta in order to divert embolic material away from the carotid arteries. This embolic matter includes but is not limited to atheromatous fragments or material, thrombus, globules of fat, air bubbles, clumps of bacteria and/or other foreign matter, tumor cells, or any other bits of tissue. The aortic diverters of the present invention can be placed surgically, endoscopically or percutaneously, and either permanently or temporarily.
- In one embodiment of the invention the aortic diverter includes two components. The first component is a hollow tube, which is substantially cylindrical, conical or frustoconical in shape. The hollow tube is an appropriate size to fit within the lumen of the ascending aorta. The proximal end of the hollow tube is adapted to fill the lumen of the aorta so that substantially all blood entering the ascending aorta from the heart must travel through the hollow tube in order to continue past the ascending aorta and into the other arteries leading to the rest of the human body. The second component is an anchoring mechanism for securing the hollow tube to the lumen of the aorta.
- In another embodiment the aortic diverter also includes two components. The first component is a hollow tube, which is substantially cylindrical, conical or frustoconical in shape. The hollow tube is an appropriate size to fit within the lumen of the ascending aorta. The proximal end of the hollow tube is adapted to fill the lumen of the aorta so that substantially all blood entering the ascending aorta from the heart must travel through the hollow tube in order to continue past the ascending aorta and into the other arteries leading to the rest of the human body. The second component is a sleeve secured to the proximal end of the hollow tube. The sleeve can be substantially rigid and circumferentially sized to frictionally anchor the hollow tube to the lumen of the aorta.
- In another embodiment, the aortic diverter is a flat, planar, snowshoe device that can be placed across the apex of the aorta in order to prevent emboli from flowing into the carotid arteries. The snowshoe diverter comprises a planar tongue and a handle, and can also include supports or legs mounted on either or both sides of the tongue. The handle is attached to the proximal end of the tongue for convenient connection to an introducing device such as a cannula, and is also useful for easy orientation and placement of the snowshoe diverter within the aorta. The handle itself can be hollow, thus acting as a cannula to supply filtered blood to the carotid arteries as well as the descending aorta. The hollow cannulated handle can be attached to the tongue such that blood flowing out of the handle and into the aorta is partitioned by the tongue to flow either anterior or posterior the tongue. Alternatively, the cannulated handle can be attached to the tongue so that all blood flowing out of the handle and into the aorta flows anterior the tongue. Alternatively, the cannulated handle can be attached to the tongue so that all blood flowing out of the handle and into the aorta flows posterior the tongue. Alternatively, the handle can be solid with no lumen for blood flow. The handle can also be flexible and bendable in order to move the handle out of the way of the surgeon. The tongue of the snowshoe diverter has a compliant framework that allows conformance with naturally irregular interval wall structures within the aorta. The framework allows the size of the tongue to be reduced allowing for introduction through small incisions, thus minimizing aortic trauma. Thus, the tongue can be rolled or folded up in any direction or manner. The framework can comprise rings that are circular or oval. Alternatively, the framework can be a figure-eight suspension frame. The tongue also has a thin, compliant membrane that is impermeable to emboli. The membrane can be made of a mesh material that may be cotton based, Teflon, nitinol, urethane or polyurethane, any combination of the above, or a combination of the above along with wire. Alternatively, the tongue can be made of material that is impermeable to blood, but have one or more way valves allowing unidirectional blood flow. The tongue can be flexible and/or elastomeric, thus enabling the tongue to be rolled or folded up in any direction or manner. The tongue can be amoeba-shaped, curved or billowed, tapered, or a combination thereof.
- The methods of the present invention relate to the prevention of cerebral embolization. Cerebral embolization can occur when emboli found in the bloodstream are carried to the brain and become lodged in the smaller blood vessels of the brain, thus obstructing blood flow to an area of the brain, which can result in a stroke. One way of protecting patients against cerebral embolization is by preventing emboli from reaching the smaller blood vessels in the brain.
- In one method of the invention an aortic diverter is provided. The aortic diverter is inserted into the aortic arch in the region of the carotid arteries. The surgeon secures the aortic diverter to the lumen of the aorta so that the proximal end of the aortic diverter extends upstream of the brachiocephalic trunk while the distal end of the aortic diverter extends downstream of the left subclavian artery. In the uncommon case where the carotid arteries directly connected to the aortic arch are just the left and right branch of the brachiocephalic trunk (see ANNE R. AGUR, GRANT's ATLAS OF ANATOMY 52 (9th ed., Williams & Wilkins 1991) (1943) (incorporated herein by reference)), the distal end of the aortic diverter extends downstream of the left brachiocephalic trunk. With the aortic diverter placed in the ascending aorta in such a manner, emboli entering the ascending aorta will necessarily have to flow through the aortic diverter and exit the distal end of the aortic diverter downstream of the carotid arteries, thus reducing the likelihood that emboli will reach the openings leading into the carotid arteries.
- In another method the surgeon provides an aortic diverter comprising a planar filter material which is impermeable to emboli but not to blood. The surgeon inserts the filter material into the aortic arch in the region of the carotid arteries. The surgeon secures the filter material to the aortic lumen so that it completely covers all of the openings leading from the aorta into the carotid arteries such that blood flowing into the carotid arteries is filtered of embolic material. The embolic material is not trapped on the filter but is washed downstream of the left subclavian artery or the left brachiocephalic trunk by the stream of blood rushing through the aorta into the peripheral vasculature.
- In another method the surgeon provides an aortic cannula. The surgeon then penetrates the wall of the aorta with the aortic cannula, which can have an inflatable balloon occluder concentrically disposed on its distal end. The aortic cannula is sutured to the wall of the aorta to prevent loss of blood. The balloon occluder can be inflated to prevent back-flow of blood towards the region of the heart. The surgeon then provides the snowshoe diverter previously described. The surgeon then inserts the snowshoe diverter through the aortic cannula and into the aortic arch in the region of the carotid arteries, thus preventing emboli from flowing into the carotid arteries. Alternatively, the snowshoe diverter can be integral with the aortic cannula and disposed on the distal end of the aortic cannula. The surgeon then provides a blood-return cannula. If the handle of the snowshoe diverter is hollow (i.e., cannulated), the surgeon can connect the blood-return cannula to the handle of the snowshoe diverter such that it is in fluid communication with the handle. If the handle of the snowshoe diverter is not hollow, then the surgeon can connect the blood-return cannula to the aortic cannula such that it is in fluid communication with the aortic cannula. Alternatively, the surgeon can insert the blood-return cannula through the wall of the aorta either upstream or downstream of the point of insertion of the aortic cannula. When protection from cerebral embolization is no longer necessary, the surgeon removes the snowshoe diverter from the aorta.
- In another method, an aortic cannula with a snowshoe aortic diverter attached to its distal end is introduced. The aortic cannula is inserted through the wall of the aorta and the snowshoe diverter is positioned in the region of the carotid arteries. The aortic cannula can be inserted through the wall of the aorta while the snowshoe diverter fully deployed. Alternatively, the snowshoe diverter can be hidden inside the lumen of the aortic cannula until after the aortic cannula is inserted through the wall of the aorta. The snowshoe diverter can then be deployed and positioned over the carotid arteries. The snowshoe diverter extends over all of the openings leading into the carotid arteries. The aortic cannula is sutured to the wall of the aorta to prevent loss of blood. A cardioplegia cannula comprising an opening in its distal end is then introduced. The cardioplegia cannula also has an inflatable balloon occluder concentrically mounted around its distal end. The cardioplegia cannula is inserted through the wall of the aorta and sutured to the wall of the aorta to prevent loss of blood. The balloon occluder is inflated to prevent all fluid flow downstream thereof, and then cardioplegia solution is delivered to the heart through the opening in the distal end of the cardioplegia cannula. Blood from a bypass machine is introduced into the aorta through aortic cannula. Blood flowing out of the distal end of the cannula and into the aorta can be partitioned by the snowshoe diverter such that some of the blood flows to the carotid arteries superior to the snowshoe diverter while the rest of the blood flows anterior the snowshoe diverter and toward the descending aorta and peripheral vasculature. Alternatively, the snowshoe device can be attached to the distal end of the aortic cannula in such a way as to divert substantially all blood exiting the distal end of the cannula to either the carotid arteries or the peripheral vasculature.
- In another method the surgeon provides an aortic diverter, which is a substantially cylindrical, conical or frustoconical hollow tube comprising a wall that is impermeable to emboli. The hollow tube is substantially flexible, is in a compressed state, and is releasably carried by an intravascular catheter for percutaneous delivery into the aorta. When deployed, the hollow tube allows blood to flow through the tube, and the proximal end of the hollow tube is circumferentially sized to completely fill the lumen of the aorta. The surgeon introduces the intravascular catheter containing the compressed aortic diverter into the vascular system. The surgeon advances the intravascular catheter into the aortic arch to the region of the carotid arteries. The surgeon deploys the aortic diverter so that the aortic diverter radially expands to contact the lumen of the aorta. In the fully deployed state, the proximal end of the aortic diverter should completely fill the lumen of the aorta and should extend upstream of the brachiocephalic trunk. The distal end of the aortic diverter should extend downstream of the left subclavian artery (or the left brachiocephalic trunk in those patients having this as the most downstream carotid artery) so that when emboli exit the distal end of the aortic diverter, they are downstream of the carotid arteries, thus reducing the likelihood that they will reach the openings leading into the carotid arteries. The surgeon then secures the aortic diverter to the lumen of the aorta, either by friction of contact or by other means discussed herein.
- The present invention addresses the dangers associated with cerebral embolization. Specifically, embolization contributes significantly to problems such as stroke, lengthy hospital stays, and, in some cases, death.
- Embolic material, which has been detected at 2.88 mm in diameter, will generally range from 0.02 mm (20 μm) to 5 mm, and consists predominantly of atheromatous fragments dislodged from the aortic wall and air bubbles introduced during dissection, but also includes platelet aggregates which form during cardiac surgery, thrombus in general, globules of fat, clumps of bacteria and/or other foreign matter, tumor cells, or any other bits of tissue. These emboli enter either the cerebral circulation or systemic arterial system. Those entering the cerebral circulation obstruct small arteries and lead to macroscopic or microscopic cerebral infarction, with ensuing neurocognitive dysfunction.
- It is an object of the present invention to eliminate or reduce the incidence of cerebral embolization. The present invention is intended to divert emboli away from the carotid arteries, which direct blood to the brain. This diversion prevents strokes, which can lead to lengthy hospital stays, damage to the brain, and sometimes death. The present invention is particularly suited for those who are at high risk of suffering from cerebral embolization, such as elderly patients and those who have atheromatosis, as well as those patients undergoing cardiac surgery, which has been shown to result in the release of emboli into the bloodstream. See, for example, Barbut et al., “Cerebral Emboli Detected During Bypass Surgery Are Associated With Clamp Removal,”Stroke, 25(12):2398-2402 (1994).
- As for the devices, one object is to provide safe and reliable devices that are easy to manufacture and use. A further object is to provide devices that may be used in the aorta, and especially in the ascending aorta. Yet another object is to provide devices that will reduce the likelihood of cerebral embolization, especially in those patients who are at high risk for cerebral embolization. Yet another object is to provide devices that can be introduced into the aorta and secured to the lumen of the aorta with minimal trauma to the patient.
- The devices disclosed herein have the following characteristics: they can withstand high arterial blood flow rates for an extended time; they can expand and contract with the wall of the aorta; they can be made of a monolithic molded material that is impermeable to blood as well as emboli, such as Teflon impregnated with an anti-thrombogenic coating or nitinol impregnated with an anti-thrombogenic coating, or they can be made of material that is impermeable to emboli and not blood, such as a mesh, a woven material, or a thin polymer; they can be biodegradable; they can include openings on their walls of any shape or predetermined pattern, wherein the openings are covered in material that is impermeable to emboli; they can be introduced surgically, endoscopically, or percutaneously with cannulas or intravascular catheters introduced through the femoral artery, subclavian artery, brachiocephalic artery, or a cut-down to the abdominal aorta; they can be left in the aorta permanently or temporarily; they can be secured to the lumen of the aorta through various mechanisms including sutures, surgical clips, hooks, adhesive material, substantially rigid sleeves, or frictional engagement; they can be flat, conical, frustoconical, or cylindrical; they can be radially self-expanding or expanded mechanically; they can be substantially rigid or substantially flexible like a “windsock;” and they can be sized to fit vessels of varying sizes.
- As for the methods of this invention, an object is to prevent cerebral embolization. The methods of this invention can be employed on various patients, especially those at high risk for cerebral embolization, in order to reduce the incidence of cerebral embolization, which can lead to neurologic or cognitive complications and death. Another object is to temporarily or permanently divert emboli away from the carotid arteries by forcing emboli downstream of the openings leading from the aorta into the carotid arteries. Another object is to provide a method for eliminating or minimizing cerebral embolization during invasive cardiac procedures. Yet another object is to provide a method of introducing an aortic diverter intravascularly or with a cannula for minimal trauma to the patient.
- Reference is next made to a brief description of the drawings, which are intended to illustrate aortic diverters and methods of their use. The drawings and detailed description which follow are intended to be merely illustrative and are not intended to limit the scope of the invention as set forth in the appended claims.
- FIG. 1 is a longitudinal view of an aorta diverter according to one embodiment, showing the aortic diverter positioned within the ascending aorta.
- FIG. 2 is a longitudinal view of an aortic diverter according to another embodiment, and in which the aortic diverter is positioned within the ascending aorta and is made of a material that is permeable to blood but impermeable to emboli.
- FIG. 3 is a longitudinal view of an aortic diverter according to another embodiment, and in which the aortic diverter is positioned within the ascending aorta and is made of a material that is impermeable to blood, wherein the aortic diverter has openings on its surface, and wherein the openings are covered with material that is permeable to blood but impermeable to emboli.
- FIG. 4 is a three-dimensional drawing of an aortic diverter according to another embodiment, showing the aortic diverter positioned across the openings leading into the carotid arteries, and in which the aortic diverter is permeable to blood but impermeable to emboli.
- FIG. 5 is a longitudinal view of a temporary aortic diverter, wherein a cannula penetrating the lumen of the ascending aorta is used to hold the aortic diverter in position during surgery, and wherein a cardioplegia cannula with a balloon occluder is used to deliver cardioplegia solution to the heart.
- FIG. 6 is a longitudinal view of an intravascular catheter with associated self-expanding aortic diverter and removable actuation sleeve.
- FIG. 7 is a cross-sectional view through section line7-7 of the device depicted in FIG. 6.
- FIG. 8 is a longitudinal view of the device depicted in FIG. 7 positioned within the ascending aorta, wherein the actuation sleeve is shown being removed to release the self-expanding aortic diverter, and the aortic diverter is shown in a self-expanding state.
- FIG. 9 is a longitudinal view of the device depicted in FIG. 8 positioned within the ascending aorta, wherein the catheter is being removed and the aortic diverter is in a fully expanded and operable state within the ascending aorta.
- FIG. 10 is a cross-sectional view through section line10-10 of the aortic diverter as it is art. percutaneously delivered to the ascending aorta.
- FIG. 11 is a longitudinal view of a cannula penetrating the lumen of the ascending aorta, wherein an aortic diverter is disposed within the cannula.
- FIG. 12 is a longitudinal view of the device depicted in FIG. 11, wherein the self-expanding aortic diverter is pushed through the cannula and is expanding as it exits the cannula.
- FIG. 13 is a longitudinal view of the device depicted in FIG. 11, wherein the aortic diverter is in a fully expanded and operable state within the ascending aorta.
- FIG. 14 is a longitudinal view of a snowshoe aortic diverter as it is inserted through the aortic cannula and into position in the aorta, wherein the blood-return cannula is in fluid communication with the aortic cannula.
- FIG. 14A is a detail of the tongue of the snowshoe diverter of FIG. 14.
- FIG. 14B is a cross-sectional view through section B-B of the snowshoe aortic diverter depicted in FIG. 14.
- FIG. 15 is a three-dimensional view of a tongue of a snowshoe aortic diverter, wherein the tongue is flat and has supports.
- FIG. 15A is a threedimensional view of a tongue of a snowshoe aortic diverter, wherein the tongue is curved or billowed.
- FIG. 15B is a three-dimensional view of a tongue of a snowshoe aortic diverter, wherein the tongue is tapered in that the proximal end of the tongue is wider than the distal end thereof.
- FIG. 15C is a three-dimensional view of a tongue of a snowshoe aortic diverter, wherein the tongue is tapered in that the proximal end of the tongue is narrower than the distal end thereof.
- FIG. 16 is a longitudinal view of a snowshoe aortic diverter positioned to prevent emboli from entering the carotid arteries, wherein a blood-return cannula is inserted through the wall of the aorta in order to allow blood into the aorta.
- FIG. 17 is a longitudinal view of a snowshoe aortic diverter, wherein the snowshoe aortic diverter is directly connected to the distal end of an aortic cannula, wherein a blood-return cannula is in fluid communication with the aortic cannula, and wherein blood entering the aorta is directed either towards the carotid arteries or posterior to the snowshoe diverter.
- FIG. 18 is a longitudinal view of a snowshoe diverter inserted upstream from a blood-return cannula and wherein blood returning to the peripheral vasculature must first pass through the snowshoe diverter.
- FIG. 19 is a longitudinal view of a snowshoe aortic diverter after it has been positioned in the region of the carotid arteries above an aortic cannula with a inflatable balloon occluder, wherein the aortic cannula allows blood to flow into the aorta, and wherein the snowshoe diverter prevents emboli from entering the carotid arteries.
- FIG. 20 is a longitudinal view of a snowshoe aortic diverter attached to the distal end of an aortic cannula with an inflatable balloon occluder, wherein blood flowing out of the distal end of the aortic cannula is diverted to flow either into the carotid arteries or anterior the snowshoe diverter and into the peripheral vasculature.
- FIG. 21 is a top view of a tapered snowshoe aortic diverter with a ring suspension frame.
- FIG. 21A is a cross-sectional view through section A-A of the snowshoe aortic diverter depicted in FIG. 21.
- FIG. 22 is a top view of a curved or billowed snowshoe aortic diverter with a ring suspension frame.
- FIG. 22A is a cross-sectional view through section A-A of the snowshoe aortic diverter depicted in FIG. 22.
- FIG. 23 is a top view of a flat snowshoe aortic diverter with supports and a ring suspension frame.
- FIG. 23A is a cross-section view through section A-A of the snowshoe aortic diverter depicted in FIG. 23.
- FIG. 24 is a top view of a flat snowshoe aortic diverter with a one-way valve.
- FIG. 24A is a cross-sectional view through section A-A of the snowshoe aortic diverter depicted in FIG. 24.
- FIG. 25 is a top view of a flat snowshoe aortic diverter with a one-way valve and a ring suspension frame.
- FIG. 25A is a cross-sectional view through section A-A of the snowshoe aortic diverter depicted in FIG. 25.
- FIG. 26 is a top view of a flat snowshoe aortic diverter with a FIG. 8 suspension frame.
- Referring more particularly to the drawings, FIG. 1 shows one embodiment of the
aortic diverter 10 for use herein. Theaortic diverter 10 is ahollow tube 20 with ananchoring mechanism 50 in connection with theproximal end 30 of thehollow tube 20. Thehollow tube 20 comprises a substantially cylindrical orconical wall 25, which is impermeable to blood. Thewall 25 of thehollow tube 20 can be made of a monolithic molded material. This material can be urethane, Teflon or nitinol, any of which may be impregnated with an anti-thrombogenic coating. However, other materials that are impermeable to blood can also be used, including materials that are biodegradable. Thehollow tube 20 has aproximal end 30 terminating in a substantially circular edge adapted to fill the lumen of the aorta or theanchoring mechanism 50. The hollow tube also has adistal end 40. Both theproximal end 30 anddistal end 40 of thehollow tube 20 are substantially open. When theaortic diverter 10 is placed in the aorta, blood flows from the heart, into the aorta, and must enter theproximal end 30 of thehollow tube 20, flow through thehollow tube 20, and exit through thedistal end 40 of thehollow tube 20. - Secured to the
proximal end 30 of thehollow tube 20 is ananchoring mechanism 50 for securing theaortic diverter 10 to the lumen of the aorta. Theanchoring mechanism 50 can be a sleeve adapted to frictionally engage the lumen of the aorta or any one of the following: one or more sutures, one or more clips, one or more hooks, or adhesive material. Alternatively, theanchoring mechanism 50 may simply comprise theproximal end 30 of thehollow tube 20 itself, which may be adapted to frictionally engage the lumen of the aorta. For example, theproximal end 30 of thehollow tube 20 may be substantially rigid, thus making it capable of being lodged into the lumen of the aorta. - The
hollow tube 20 can be substantially rigid or a flexible windsock. Furthermore, where thehollow tube 20 is a flexible windsock, theproximal end 30 may still be substantially rigid for frictional engagement with the lumen of the aorta. - The
aortic diverter 10 depicted in FIG. 1 prevents emboli from reaching the carotid arteries because it prevents lateral blood flow to the carotid arteries. Blood reaches the carotid arteries due to back-flow over thedistal end 40 of theaortic diverter 10. Atherembolic material continue downstream because they are less susceptible to being swept retrograde due to their greater density over blood. - Referring now to both FIGS. 2 and 3, FIG. 2 shows the
aortic diverter 10 with awall 25 that is made of a material that is permeable to blood but impermeable to emboli. Thewall 25 can be made of a mesh material, a woven material, a thin polymer, or any material that is permeable to blood but impermeable to emboli, including material that is biodegradable. Furthermore, as depicted in theaortic diverter 10 of FIG. 3, thewall 25 of thehollow tube 20 can be impermeable to blood, but haveopenings 70 that are covered withmaterial 80 that is permeable to blood yet impermeable to emboli. When placed in the aorta, blood flows from the heart, into the aorta, and must enter theproximal end 30 of thehollow tube 20, flow through thehollow tube 20, and exit either through thedistal end 40 of thehollow tube 20 or laterally through the blood-permeable wall 25 of FIG. 2 or theopenings 70 of FIG. 3. Since thewall 25 of FIG. 2 and theopenings 70 of FIG. 3 are impermeable to emboli, emboli are washed downstream with the current of blood that takes the emboli to the peripheral vasculature. The distal end of theaortic diverter 10 may also be adapted to completely fill the lumen of the aorta such that there is no backflow of blood to the carotid arteries. There is no need for backflow because blood flows to the carotid arteries laterally through thewall 25 of FIG. 2 or theopenings 70 of FIG. 3. - The
aortic diverter 10, depicted in FIGS. 2 and 3 respectively, prevent emboli from reaching the carotid arteries because emboli cannot laterally pass through thewall 25 of FIG. 2, or alternatively theopenings 70 of FIG. 3. Furthermore, the danger of backflow carrying emboli to the carotid arteries is reduced because the pressure caused by lateral blood flow through thewall 25 of FIG. 2, or alternatively theopenings 70 of FIG. 3, counteracts with the backflow pressure, reducing the amount of blood that reaches the carotid arteries due to backflow. Moreover, when thedistal end 40 of theaortic diverter 10 is adapted to fill the lumen of the aorta, there is no backflow to the carotid arteries. In either case, emboli are washed downstream and into the peripheral vasculature without ever reaching the carotid arteries. - Referring now only to FIG. 3, the
openings 70 can be of any shape including circles, ovals, rectangles, octagons, squares, or slits. Thewall 25 of thehollow tube 20 may include oneopening 70 or a plurality ofopenings 70. Theopenings 70 can be radially disposed along the circumference of thehollow tube 20 or longitudinally disposed along the length of thehollow tube 20. The openings can be one or more continuous rings disposed along the circumference of thehollow tube 20, or one or more continuous columns longitudinally disposed along the length of thehollow tube 20. - Referring now to FIGS. 1, 2 and3, the substantially rigid
proximal end 30 may be lodged into the lumen of the aorta by surgically placing theproximal end 30 at a point where theproximal end 30 has a larger circumference than the lumen of the aorta. Alternatively, thehollow tube 20 can be introduced into the aorta in a compressed, but rigidly expandable state, either percutaneously or surgically. Thehollow tube 20 can then be allowed to self-expand or forced to radially expand into frictional engagement with the lumen of the aorta. - FIGS. 6 through 10 show one method of introducing and positioning
aortic diverter 10 in the ascending aorta. FIGS. 6 through 10 showaortic diverter 10, which is self-expanding, loaded ontoassembly 90 for percutaneous delivery. Theintravascular catheter 110 operates over astandard guidewire 100.Aortic diverter 10 expands between a compressed state and a radially expanded state. FIGS. 6 and 7 showaortic diverter 10 contained in a compressed state by generallyinelastic sleeve 130, which surroundsdiverter 10 and prevents it from self-expanding. - FIG. 8 shows the
intravascular catheter assembly 90 positioned in the ascending aorta. Onceassembly 90 is correctly positioned, thesleeve 130 is pulled back, thus allowingaortic diverter 10 to deploy. Then, as depicted in FIG. 9, once the sleeve is completely removed,diverter 10 is released, andintravascular catheter 110 is pulled back along the guidewire and removed. Theproximal end 30 of theaortic diverter 10 completely fills the lumen of the aorta so that substantially all blood flowing into the ascending aorta must pass through theaortic diverter 10. FIG. 10 is a cross sectional view through line 10-10 of FIG. 9 and shows that thewall 25 of theaortic diverter 10 is in continuous radial contact with and completely fills the lumen of theaorta 5. Thedistal end 40 of theaortic diverter 10 may also completely fill the lumen of theaorta 5 if thewall 25 of the aortic diverter is made of material that is permeable to blood, as in FIGS. 2 and 3. FIGS. 11 through 13 show another method of delivering theaortic diverter 10 to the ascending aorta. In this method, theaortic diverter 10 is again self-expanding, but is delivered with acannula 140 that directly penetrates the lumen of the aorta. FIG. 11 shows thecannula 140, after having penetrated the aorta, with theaortic diverter 10 contained within the barrel of thecannula 140. Once thecannula 140 is in position for delivery of theaortic diverter 10, apiston rod 160 with apiston 170 attached to its distal end is advanced toward thedistal end 150 or outlet of the cannula. As thepiston rod 160 is advanced thepiston 170 pushes against theproximal end 30 of theaortic diverter 10, which is in a compressed state, forcing theaortic diverter 10 toward theoutlet 150 of thecannula 140. FIG. 12 shows theaortic diverter 10 emerging from theoutlet 150 of thecannula 140 and self-expanding since it is no longer contained in a compressed state. FIG. 13 shows theaortic diverter 10 completely deployed and operable. Theproximal end 10 of theaortic diverter 10 completely fills the lumen of the aorta such that substantially all blood flowing into the aorta from the heart must flow through theaortic diverter 10. Thedistal end 40 of theaortic diverter 10 may also completely fill the lumen of the aorta if thewall 25 of theaortic diverter 10 is permeable to blood but impermeable to emboli as in FIGS. 2 and 3. - FIG. 4 shows another embodiment of an
aortic diverter 85 comprising a substantially planar filter material which is permeable to blood but impermeable to emboli. Theaortic diverter 85 can be anchored to the lumen of the aorta with one of the following: one or more sutures, clips, hooks, or adhesive material. By placing theaortic diverter 85 so that it simultaneously covers all of the openings leading from the aorta into the carotid arteries, theaortic diverter 85 prevents emboli from entering the carotid arteries. As blood flows through the blood-permeable material of theaortic diverter 85, emboli are blocked and are swept downstream with the current of blood. - The
aortic diverter 85 can be substantially rigid or flexible and surgically, endoscopically, or percutaneously delivered to the aorta. Percutaneous delivery can be accomplished using anintravascular catheter assembly 90 as in FIG. 6 and constructing theaortic diverter 85 so that it is self-expanding and concentrically mountable around theintravascular catheter 110. Once deployed, theaortic diverter 85 can be secured to the lumen of the aorta with various anchoring mechanisms disclosed in the preceding paragraph. - Surgical delivery of the
aortic diverter 85 can be accomplished using a method similar to the one depicted in FIGS. 11-13. Theaortic diverter 85 can be compressibly disposed within the barrel of thecannula 140 and constructed to self-expand when no longer constrained by the walls of thecannula 140. Again, theaortic diverter 85 can be secured to the lumen of the aorta with the various anchoring mechanisms previously disclosed. - Procedures such as incising, clamping, clamp release, and balloon occluding, which are applied during cardiopulmonary bypass, are known to cause embolization. For example, during cardiac surgery, the aorta is clamped or balloon-occluded. Because clamping and/or balloon occluding the aorta dislodges atheromatous material from the walls of the aorta, which is released into the bloodstream, an aortic diverter is needed before clamping and/or balloon occluding begins in order to divert embolic material away from the carotid arteries. Atheromatous material also accumulates behind clamps during surgery and, because removal of the clamps releases this material into the bloodstream, an aortic diverter must be maintained within the bloodstream for about four to ten minutes after removal of the clamps.
- FIG. 5 shows a “snowshoe”
aortic diverter 200 attached to the distal end of a cannula for temporary diversion of embolic material away from the carotid arteries during cardiopulmonary bypass. For illustration purposes, the method for diverting emboli away from the carotid arteries will be described in connection with the “snowshoe”aortic diverter 200 depicted in FIG. 5. After a patient has been anaesthetized and the patient's chest has been opened in preparation for surgery, thecannula 205 withaortic diverter 200 attached to thedistal end 210 of thecannula 205 is introduced into an incision made in the aorta. Alternatively, theaortic diverter 200 may be inside the cannula and advanced through thedistal end 210 of thecannula 205 after thecannula 205 is introduced into the incision made in the aorta. Theaortic diverter 200 is positioned in the aorta, extending over all of the openings leading to the carotid arteries, in order to ensure that emboli do not reach the brain. Thecannula 205 is sutured to the aortic wall. Then acardioplegia cannula 230 with aballoon occluder 250 attached to itsdistal end 245 is introduced into another incision made in the aorta. Thecardioplegia cannula 230 is sutured to the aortic wall. Theballoon occluder 250 is inflated in order to block all fluid flow downstream thereof, and thecardioplegia cannula 230 then delivers cardioplegic solution through anopening 240 in its distal end into the heart, thereby causing the heart to be paralyzed. Balloon occluding may inadvertently dislodge atheromatous material from the walls of the aorta and release it into the bloodstream. However, theaortic diverter 200 prevents the atheromatous material from entering the carotid arteries. Blood from a bypass machine is introduced into the aorta through thecannula 210. Once surgery is complete, bypass is discontinued, and the balloon occluder is deflated, thereby releasing more atheromatous material. Theaortic diverter 200 is left in position for four to ten minutes and then removed. - FIG. 14 depicts another implementation of
snowshoe diverter 200 deployed withinaorta 306.Cannula 205 includesside channel 301 for receiving filtered blood from a bypass machine (not shown). The blood travels throughcannula 205, and is split into a first stream 302 (blood supply for carotid arteries) and a second stream 303 (blood supply for descending aorta) as it passes from blood supply channel 305 (FIG. 14B).Cannula 205 therefore delivers oxygenated blood to the aorta above and belowdiverter 200, so that the stream of blood is split. FIG. 14A is an expanded longitudinal view ofdiverter 200 withhandle 304, while FIG. 14B shows a cross-section taken through section lines 14B in FIG. 14, and showingdiverter 200 andblood supply channels 305. - FIGS.15-15C show various configurations for the diverting
member 200. FIG. 15 shows amoeba-shapedtongue diverter 200 having external wire supports 308 attached. FIG. 15A showscurved tongue diverter 200, which may, in some embodiments include wire supports (not shown). A diverter in the shape of a tapered tongue is depicted in FIGS. 15B and 15C. The diverter tongue may be comprised of a mesh (free of polyurethane), a mesh-polyurethane composite, or a mesh-polyurethane-wire composite. The diverter tongue may be constructed with or without wire supports. - In FIG. 16,
cannula 205 is used to deploydiverter 200 inaorta 306, whileseparate cannula 307 delivers oxygenated blood to the aorta.Diverter 200 is porous for this implementation, thus permitting blood to enter cerebral circulation by passing throughdiverter 200. Thus, it will be understood that the diverter tongue may be deployed above the aortic cannula (FIG. 16), below the aortic cannula (FIG. 18), or midway with respect to the aortic cannula (FIG. 17). The diverter may be integral with the cannula, separately insertable through the cannula, or inserted through a separate stick in the aorta. The diverter may be part of an aortic occluder in certain embodiments (FIGS. 19 and 20).Balloon occluder 311 is circumferentially disposed aboutcannula 205, anddiverter 200 is deployed therethrough (FIG. 20). A top-mounted diverter structure is shown in FIG. 19, but it will be understood that a bottom-mounted structure would also be advantageous, and would deliver blood above the diverter.Cannula 205 optionally includesflange 310 to ensure proper placement and positioning throughaorta 306. - FIG. 21 shows a
tapered tongue diverter 200 havingsuspension ring 315 mounted therein. FIG. 21A depicts an end view of the diverter of FIG. 21.Suspension ring 315 is a collapsible force biasing element which holdsframe 317 in an open position when not compressed.Ring 315 is collapsible to permit loading and delivery through a standard cannula. FIG. 22 shows a snowshoe diverter with a curved or billowed membrane (see FIG. 22A cross-section), mesh, valve, or combination thereof. FIG. 23 shows a diverter having a plurality oflegs 316, or external wire supports. - In another embodiment shown in FIG. 24,
diverter 200 includes a flap valve formed by overlap ofedges 320 of diverter 200 (see FIG. 24A cross-section). The flap valve allows blood to flow in one direction (see FIG. 24B). Thus, such a snowshoe is particularly useful for deployment below the blood cannula (see FIG. 18). Each flap of the diverter is formed of a nonporous membrane, filter mesh material, combination membrane and filter, one way flap valve, or flap valve with filter. This same design can be implemented with suspension ring 315 (see FIG. 25), multiple suspension rings (not shown), or a figure-eight suspension frame (see FIG. 26). - All publications and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. While particular devices and methods have been described for diverting emboli away from the carotid arteries, once this description is known, it will be apparent to those of ordinary skill in the art that other embodiments and alternative steps are also possible without departing from the spirit and scope of the invention. Moreover, it will be apparent that certain features of each embodiment can be used in combination with devices illustrated in other embodiments. Accordingly, the above description should be construed as illustrative, and not in a limiting sense, the scope of the invention being defined by the following claims.
Claims (12)
1. A catheter apparatus for use in a body passage, comprising:
a catheter shaft;
an expandable conduit defined by a filter mesh material of varying porosity mounted on said catheter shaft, said expandable conduit having an upstream end and a downstream end, said expandable conduit having a collapsed position in which said expandable conduit is collapsed toward said catheter shaft and an expanded position in which said upstream end of said expandable conduit is open to fluid flow; and
an upstream sealing member at said upstream end of said expandable conduit for creating a seal between said upstream end of said expandable conduit and an internal wall of the body passage.
2. The catheter apparatus of claim 1 , wherein said upstream sealing member comprises an inflatable toroidal balloon.
3. The catheter apparatus of claim 1 , further comprising a perfusion lumen within said catheter shaft in fluid communication with a space exterior to said expandable conduit.
4. The catheter apparatus of claim 1 , wherein said expandable conduit further comprises at least one longitudinal support member attached to a wall of said expandable conduit.
5. The catheter apparatus of claim 1 , wherein said expandable conduit further comprises an end wall of porous fabric across said downstream end of said expandable conduit.
6. The catheter apparatus of claim 1 , further comprising an occlusion member for selectively occluding said expandable conduit.
7. The catheter apparatus of claim 6 , further comprising an infusion lumen within said catheter shaft having an infusion port upstream of said occlusion member.
8. The catheter apparatus of claim 7 , further comprising a second perfusion lumen within said catheter shaft.
9. The catheter apparatus of claim 1 , further comprising a tubular sheath sized to fit over said expandable conduit when in said collapsed position.
10. The catheter apparatus of claim 6 , wherein said occlusion member is an inflatable occlusion balloon.
11. The catheter apparatus of claim 1 , wherein said catheter shaft is positioned external to said expandable conduit.
12. The catheter apparatus of claim 1 , wherein said catheter shaft is positioned internal to said expandable conduit.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/077,312 US20020077596A1 (en) | 1997-05-12 | 2002-02-15 | Perfusion shunt apparatus and method |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/854,806 US6231544B1 (en) | 1996-05-14 | 1997-05-12 | Cardioplegia balloon cannula |
US08/993,202 US6048331A (en) | 1996-05-14 | 1997-12-18 | Cardioplegia occluder |
US08/996,532 US6258120B1 (en) | 1997-12-23 | 1997-12-23 | Implantable cerebral protection device and methods of use |
US09/016,714 US6592546B1 (en) | 1996-05-14 | 1998-01-30 | Aortic occluder with associated filter and methods of use during cardiac surgery |
US09/387,634 US6176851B1 (en) | 1996-05-14 | 1999-08-31 | Cardioplegia occluder |
US09/467,293 US6966902B2 (en) | 1996-05-14 | 1999-12-17 | Balloon occlusion device and methods of use |
US09/642,570 US6499487B1 (en) | 1997-12-23 | 2000-08-17 | Implantable cerebral protection device and methods of use |
US10/077,312 US20020077596A1 (en) | 1997-05-12 | 2002-02-15 | Perfusion shunt apparatus and method |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/016,714 Continuation-In-Part US6592546B1 (en) | 1996-05-14 | 1998-01-30 | Aortic occluder with associated filter and methods of use during cardiac surgery |
US09/642,570 Continuation US6499487B1 (en) | 1997-05-12 | 2000-08-17 | Implantable cerebral protection device and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020077596A1 true US20020077596A1 (en) | 2002-06-20 |
Family
ID=25543016
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/996,532 Expired - Lifetime US6258120B1 (en) | 1997-05-12 | 1997-12-23 | Implantable cerebral protection device and methods of use |
US09/642,570 Expired - Lifetime US6499487B1 (en) | 1997-05-12 | 2000-08-17 | Implantable cerebral protection device and methods of use |
US10/077,312 Abandoned US20020077596A1 (en) | 1997-05-12 | 2002-02-15 | Perfusion shunt apparatus and method |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/996,532 Expired - Lifetime US6258120B1 (en) | 1997-05-12 | 1997-12-23 | Implantable cerebral protection device and methods of use |
US09/642,570 Expired - Lifetime US6499487B1 (en) | 1997-05-12 | 2000-08-17 | Implantable cerebral protection device and methods of use |
Country Status (7)
Country | Link |
---|---|
US (3) | US6258120B1 (en) |
EP (1) | EP1041940B1 (en) |
AT (1) | ATE387153T1 (en) |
AU (1) | AU745809B2 (en) |
CA (3) | CA2316237C (en) |
DE (1) | DE69839193T2 (en) |
WO (1) | WO1999032050A1 (en) |
Cited By (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050033360A1 (en) * | 2001-11-08 | 2005-02-10 | Sing Eduardo Chi | Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US20060161241A1 (en) * | 2005-01-14 | 2006-07-20 | Denise Barbut | Methods and devices for treating aortic atheroma |
US20060178694A1 (en) * | 2003-05-19 | 2006-08-10 | Secant Medical, Llc | Tissue distention device and related methods for therapeutic intervention |
US20060229660A1 (en) * | 2005-03-15 | 2006-10-12 | Dharmendra Pal | Embolic protection device |
US20070270901A1 (en) * | 2006-05-08 | 2007-11-22 | Shimon Dov V | Device and method for vascular filter |
US20080065145A1 (en) * | 2006-09-11 | 2008-03-13 | Carpenter Judith T | Embolic protection device and method of use |
US20080064957A1 (en) * | 2006-09-07 | 2008-03-13 | Spence Paul A | Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head |
US20080109055A1 (en) * | 2006-11-02 | 2008-05-08 | Sage Medical Technologies, Inc. | Implant for aortic dissection and methods of use |
US20080140110A1 (en) * | 2006-12-12 | 2008-06-12 | Spence Paul A | Implant, systems and methods for physically diverting material in blood flow away from the head |
US20090069841A1 (en) * | 2006-05-23 | 2009-03-12 | Pah Gunnar M | Device for Filtering of Blood During Removal of Heart Valve Stenosis and Method of Removing Heart Valve Stenosis |
US20100179647A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure |
US20100179585A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Embolic deflection device |
US20100185231A1 (en) * | 2009-01-16 | 2010-07-22 | Lashinski Randall T | Intravascular Blood Filter |
US20100191276A1 (en) * | 2009-01-29 | 2010-07-29 | Lashinski Randall T | Illuminated Intravascular Blood Filter |
US7766934B2 (en) | 2005-07-12 | 2010-08-03 | Cook Incorporated | Embolic protection device with an integral basket and bag |
US7771452B2 (en) | 2005-07-12 | 2010-08-10 | Cook Incorporated | Embolic protection device with a filter bag that disengages from a basket |
US20100211095A1 (en) * | 2006-09-11 | 2010-08-19 | Carpenter Judith T | Embolic Protection Device and Method of Use |
US7850708B2 (en) | 2005-06-20 | 2010-12-14 | Cook Incorporated | Embolic protection device having a reticulated body with staggered struts |
US20110022076A1 (en) * | 2009-07-27 | 2011-01-27 | Lashinski Randall T | Dual Endovascular Filter and Methods of Use |
US8109962B2 (en) | 2005-06-20 | 2012-02-07 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US8152831B2 (en) | 2005-11-17 | 2012-04-10 | Cook Medical Technologies Llc | Foam embolic protection device |
US8182508B2 (en) | 2005-10-04 | 2012-05-22 | Cook Medical Technologies Llc | Embolic protection device |
US8187298B2 (en) | 2005-08-04 | 2012-05-29 | Cook Medical Technologies Llc | Embolic protection device having inflatable frame |
US8216269B2 (en) | 2005-11-02 | 2012-07-10 | Cook Medical Technologies Llc | Embolic protection device having reduced profile |
US8252017B2 (en) | 2005-10-18 | 2012-08-28 | Cook Medical Technologies Llc | Invertible filter for embolic protection |
US8252018B2 (en) | 2007-09-14 | 2012-08-28 | Cook Medical Technologies Llc | Helical embolic protection device |
US8377092B2 (en) | 2005-09-16 | 2013-02-19 | Cook Medical Technologies Llc | Embolic protection device |
US8388644B2 (en) | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
US8419748B2 (en) | 2007-09-14 | 2013-04-16 | Cook Medical Technologies Llc | Helical thrombus removal device |
US8632562B2 (en) | 2005-10-03 | 2014-01-21 | Cook Medical Technologies Llc | Embolic protection device |
US8795315B2 (en) | 2004-10-06 | 2014-08-05 | Cook Medical Technologies Llc | Emboli capturing device having a coil and method for capturing emboli |
US20140257368A1 (en) * | 2008-09-04 | 2014-09-11 | Swat Medical Ab | Temporary Embolic Protection Device And Medical Procedure For Delivery Thereof |
US8876796B2 (en) | 2010-12-30 | 2014-11-04 | Claret Medical, Inc. | Method of accessing the left common carotid artery |
US8945169B2 (en) | 2005-03-15 | 2015-02-03 | Cook Medical Technologies Llc | Embolic protection device |
US8999364B2 (en) | 2004-06-15 | 2015-04-07 | Nanyang Technological University | Implantable article, method of forming same and method for reducing thrombogenicity |
US9138307B2 (en) | 2007-09-14 | 2015-09-22 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US20150297250A1 (en) * | 2014-04-16 | 2015-10-22 | Covidien Lp | Systems and methods for catheter advancement |
US9326843B2 (en) | 2009-01-16 | 2016-05-03 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US9370438B2 (en) | 2011-11-10 | 2016-06-21 | Transaortic Medical, Inc. | Method for deploying a device to a distal location across a diseased vessel |
CN106102654A (en) * | 2014-01-10 | 2016-11-09 | 企斯动哈特有限公司 | Dissect independent deflector |
US9545298B2 (en) | 2011-11-10 | 2017-01-17 | Transaortic Medical, Inc. | System for deploying a device to a distal location across a diseased vessel |
US9566144B2 (en) | 2015-04-22 | 2017-02-14 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
US9636205B2 (en) | 2009-01-16 | 2017-05-02 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US9668849B2 (en) | 2001-12-05 | 2017-06-06 | Keystone Heart Ltd. | Endovascular device for entrapment of participate matter and method for use |
US20170182295A1 (en) * | 2015-12-28 | 2017-06-29 | Boston Scientific Scimed, Inc. | Medical devices with antithrombogenic coatings |
US9901434B2 (en) | 2007-02-27 | 2018-02-27 | Cook Medical Technologies Llc | Embolic protection device including a Z-stent waist band |
US9908143B2 (en) | 2008-06-20 | 2018-03-06 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
US9907639B2 (en) | 2006-09-19 | 2018-03-06 | Cook Medical Technologies Llc | Apparatus and methods for in situ embolic protection |
CN110916851A (en) * | 2019-11-29 | 2020-03-27 | 复旦大学附属中山医院 | Universal heart valve intervention forming system |
US10646359B2 (en) | 2008-06-20 | 2020-05-12 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
US20200268500A1 (en) * | 2017-09-28 | 2020-08-27 | Zeev Brandeis | Aortic protection |
US11154390B2 (en) | 2017-12-19 | 2021-10-26 | Claret Medical, Inc. | Systems for protection of the cerebral vasculature during a cardiac procedure |
US11191630B2 (en) | 2017-10-27 | 2021-12-07 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11213318B2 (en) | 2011-11-10 | 2022-01-04 | Medtronic Vascular, Inc. | Expandable introducer sheath and method |
US11234845B2 (en) | 2013-05-17 | 2022-02-01 | Medtronic, Inc. | Expandable introducer sheath |
US11337790B2 (en) | 2017-02-22 | 2022-05-24 | Boston Scientific Scimed, Inc. | Systems and methods for protecting the cerebral vasculature |
US11351023B2 (en) | 2018-08-21 | 2022-06-07 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11382734B2 (en) | 2019-08-19 | 2022-07-12 | Encompass Technologies, Inc. | Embolic filter with controlled aperture size distribution |
US11439491B2 (en) | 2018-04-26 | 2022-09-13 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11559672B2 (en) | 2019-02-08 | 2023-01-24 | Nxt Biomedical, Llc | Left atrial appendage stasis reduction |
US11607301B2 (en) | 2009-01-16 | 2023-03-21 | Boston Scientific Scimed, Inc. | Intravascular blood filters and methods of use |
WO2024042528A1 (en) * | 2022-08-25 | 2024-02-29 | Capricon Medical Ltd | Protecting coronary arteries and myocardium blood vessels during medical procedures |
US11931484B2 (en) | 2008-06-20 | 2024-03-19 | Razmodics Llc | Composite stent having multi-axial flexibility and method of manufacture thereof |
Families Citing this family (308)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006134A (en) * | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US6371935B1 (en) | 1999-01-22 | 2002-04-16 | Cardeon Corporation | Aortic catheter with flow divider and methods for preventing cerebral embolization |
US6395014B1 (en) | 1997-09-26 | 2002-05-28 | John A. Macoviak | Cerebral embolic protection assembly and associated methods |
EP1752112B1 (en) | 1997-11-07 | 2009-12-23 | Salviac Limited | An embolic protection device |
US7491216B2 (en) | 1997-11-07 | 2009-02-17 | Salviac Limited | Filter element with retractable guidewire tip |
US6695864B2 (en) * | 1997-12-15 | 2004-02-24 | Cardeon Corporation | Method and apparatus for cerebral embolic protection |
US6159178A (en) * | 1998-01-23 | 2000-12-12 | Heartport, Inc. | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
US6849088B2 (en) | 1998-09-30 | 2005-02-01 | Edwards Lifesciences Corporation | Aorto uni-iliac graft |
AUPQ302999A0 (en) * | 1999-09-23 | 1999-10-21 | Endogad Research Pty Limited | Pre-shaped intraluminal graft |
US6896690B1 (en) * | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US20040167613A1 (en) * | 1999-03-11 | 2004-08-26 | Ofer Yodfat | Implantable stroke prevention device |
IL128938A0 (en) * | 1999-03-11 | 2000-02-17 | Mind Guard Ltd | Implantable stroke treating device |
US6673089B1 (en) | 1999-03-11 | 2004-01-06 | Mindguard Ltd. | Implantable stroke treating device |
US6478818B1 (en) * | 1999-04-01 | 2002-11-12 | Syde A. Taheri | Arterial bypass procedure |
US6918921B2 (en) | 1999-05-07 | 2005-07-19 | Salviac Limited | Support frame for an embolic protection device |
US6964672B2 (en) | 1999-05-07 | 2005-11-15 | Salviac Limited | Support frame for an embolic protection device |
US6387116B1 (en) * | 1999-06-30 | 2002-05-14 | Pharmasonics, Inc. | Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts |
US8083766B2 (en) | 1999-09-13 | 2011-12-27 | Rex Medical, Lp | Septal defect closure device |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
IT1311589B1 (en) * | 1999-11-22 | 2002-03-13 | Alberto Cremonesi | DEVICE FOR VASCULAR IMPLANTATION IN THE PERCUTANEOUS TREATMENT OF CAROTID INJURY. |
EP1237487A4 (en) * | 1999-12-06 | 2010-11-03 | Simcha Milo | Ultrasonic medical device |
US6402771B1 (en) | 1999-12-23 | 2002-06-11 | Guidant Endovascular Solutions | Snare |
US6660021B1 (en) | 1999-12-23 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Intravascular device and system |
US6575997B1 (en) | 1999-12-23 | 2003-06-10 | Endovascular Technologies, Inc. | Embolic basket |
US6695813B1 (en) | 1999-12-30 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US7918820B2 (en) | 1999-12-30 | 2011-04-05 | Advanced Cardiovascular Systems, Inc. | Device for, and method of, blocking emboli in vessels such as blood arteries |
IL140871A0 (en) * | 2001-01-11 | 2002-02-10 | Mind Guard Ltd | Implantable composite stroke preventing device and method of manufacturing |
US20040010307A1 (en) * | 2000-01-18 | 2004-01-15 | Mindguard Ltd. | Implantable integral device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US6929653B2 (en) * | 2000-12-15 | 2005-08-16 | Medtronic, Inc. | Apparatus and method for replacing aortic valve |
US6692513B2 (en) | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
US7749245B2 (en) * | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
GB2369575A (en) | 2000-04-20 | 2002-06-05 | Salviac Ltd | An embolic protection system |
US6964670B1 (en) | 2000-07-13 | 2005-11-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection guide wire |
IL137326A0 (en) * | 2000-07-17 | 2001-07-24 | Mind Guard Ltd | Implantable braided stroke preventing device and method of manufacturing |
JP2004506469A (en) | 2000-08-18 | 2004-03-04 | アトリテック, インコーポレイテッド | Expandable implantable device for filtering blood flow from the atrial appendage |
US6572652B2 (en) * | 2000-08-29 | 2003-06-03 | Venpro Corporation | Method and devices for decreasing elevated pulmonary venous pressure |
US6506203B1 (en) | 2000-12-19 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Low profile sheathless embolic protection system |
US6562066B1 (en) * | 2001-03-02 | 2003-05-13 | Eric C. Martin | Stent for arterialization of the coronary sinus and retrograde perfusion of the myocardium |
US6599307B1 (en) | 2001-06-29 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Filter device for embolic protection systems |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US7338510B2 (en) | 2001-06-29 | 2008-03-04 | Advanced Cardiovascular Systems, Inc. | Variable thickness embolic filtering devices and method of manufacturing the same |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
US20030100945A1 (en) | 2001-11-23 | 2003-05-29 | Mindguard Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US20030023263A1 (en) * | 2001-07-24 | 2003-01-30 | Incept Llc | Apparatus and methods for aspirating emboli |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US6845776B2 (en) | 2001-08-27 | 2005-01-25 | Richard S. Stack | Satiation devices and methods |
US20040117031A1 (en) * | 2001-08-27 | 2004-06-17 | Stack Richard S. | Satiation devices and methods |
CN101810521B (en) | 2001-08-27 | 2015-05-13 | 辛尼科有限责任公司 | Satiation devices and methods |
US6675809B2 (en) | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US7097665B2 (en) * | 2003-01-16 | 2006-08-29 | Synecor, Llc | Positioning tools and methods for implanting medical devices |
US6638294B1 (en) | 2001-08-30 | 2003-10-28 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
US6592606B2 (en) | 2001-08-31 | 2003-07-15 | Advanced Cardiovascular Systems, Inc. | Hinged short cage for an embolic protection device |
US6656351B2 (en) * | 2001-08-31 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices one way porous membrane |
US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US8262689B2 (en) | 2001-09-28 | 2012-09-11 | Advanced Cardiovascular Systems, Inc. | Embolic filtering devices |
US20030114923A1 (en) * | 2001-11-14 | 2003-06-19 | Swanick Thomas M. | Graft and method of making |
US6770090B2 (en) * | 2001-12-07 | 2004-08-03 | Scimed Life Systems, Inc. | Anatomically curved graft for implantation at the aortic arch |
US7241304B2 (en) | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
AU2002351156A1 (en) * | 2001-12-21 | 2003-07-15 | Salviac Limited | A support frame for an embolic protection device |
US6893413B2 (en) | 2002-01-07 | 2005-05-17 | Eric C. Martin | Two-piece stent combination for percutaneous arterialization of the coronary sinus and retrograde perfusion of the myocardium |
US7037329B2 (en) * | 2002-01-07 | 2006-05-02 | Eric C. Martin | Bifurcated stent for percutaneous arterialization of the coronary sinus and retrograde perfusion of the myocardium |
US20030158571A1 (en) * | 2002-02-15 | 2003-08-21 | Esch Brady D. | Aortic flow divider for cerebral and coronary embolic protection |
US20030158574A1 (en) * | 2002-02-15 | 2003-08-21 | Esch Brady D. | Flow-through aortic flow divider for cerebral and coronary embolic protection |
US7146984B2 (en) * | 2002-04-08 | 2006-12-12 | Synecor, Llc | Method and apparatus for modifying the exit orifice of a satiation pouch |
US8721713B2 (en) | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
US7044962B2 (en) * | 2002-06-25 | 2006-05-16 | Scimed Life Systems, Inc. | Implantable prosthesis with displaceable skirt |
WO2004019817A1 (en) * | 2002-08-27 | 2004-03-11 | Amir Belson | Embolic protection device |
US7252675B2 (en) | 2002-09-30 | 2007-08-07 | Advanced Cardiovascular, Inc. | Embolic filtering devices |
US7331973B2 (en) | 2002-09-30 | 2008-02-19 | Avdanced Cardiovascular Systems, Inc. | Guide wire with embolic filtering attachment |
US20040088000A1 (en) | 2002-10-31 | 2004-05-06 | Muller Paul F. | Single-wire expandable cages for embolic filtering devices |
WO2004043293A2 (en) * | 2002-11-13 | 2004-05-27 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US20040143342A1 (en) | 2003-01-16 | 2004-07-22 | Stack Richard S. | Satiation pouches and methods of use |
US8591540B2 (en) | 2003-02-27 | 2013-11-26 | Abbott Cardiovascular Systems Inc. | Embolic filtering devices |
US20100196345A1 (en) * | 2003-04-27 | 2010-08-05 | Protalix | Production of high mannose proteins in plant culture |
US7951557B2 (en) * | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
WO2004098419A1 (en) * | 2003-05-07 | 2004-11-18 | Institut De Cardiologie De Montréal /Montreal Heart Institute | Intracoronary shunt |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US20050247320A1 (en) | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US8206456B2 (en) | 2003-10-10 | 2012-06-26 | Barosense, Inc. | Restrictive and/or obstructive implant system for inducing weight loss |
US7892251B1 (en) | 2003-11-12 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Component for delivering and locking a medical device to a guide wire |
US7186265B2 (en) | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US7988724B2 (en) | 2003-12-23 | 2011-08-02 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US20050137686A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
EP2526895B1 (en) | 2003-12-23 | 2014-01-29 | Sadra Medical, Inc. | Repositionable heart valve |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US20050137687A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
US7678129B1 (en) | 2004-03-19 | 2010-03-16 | Advanced Cardiovascular Systems, Inc. | Locking component for an embolic filter assembly |
WO2005094725A1 (en) * | 2004-03-31 | 2005-10-13 | Merlin Md Pte Ltd | A method for treating aneurysms |
US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
EP1753374A4 (en) | 2004-04-23 | 2010-02-10 | 3F Therapeutics Inc | Implantable prosthetic valve |
EP1740132B1 (en) | 2004-04-26 | 2014-12-31 | Synecor, LLC | Restrictive and/or obstructive implant for inducing weight loss |
US20050267516A1 (en) * | 2004-06-01 | 2005-12-01 | Farzad Soleimani | Embolic protection device for the prevention of stroke |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
US7927346B2 (en) * | 2004-09-10 | 2011-04-19 | Stryker Corporation | Diversion device to increase cerebral blood flow |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US7674238B2 (en) * | 2004-12-23 | 2010-03-09 | Boston Scientific Scimed, Inc. | Methods and apparatus for emboli removal |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
US9259305B2 (en) | 2005-03-31 | 2016-02-16 | Abbott Cardiovascular Systems Inc. | Guide wire locking mechanism for rapid exchange and other catheter systems |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US20080255603A1 (en) * | 2005-06-10 | 2008-10-16 | Sagax, Inc. | Implant Device Particularly Useful For Implantation In the Intravascular System For Diverting Emboli |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
EP1945142B1 (en) | 2005-09-26 | 2013-12-25 | Medtronic, Inc. | Prosthetic cardiac and venous valves |
US9055942B2 (en) * | 2005-10-03 | 2015-06-16 | Boston Scienctific Scimed, Inc. | Endoscopic plication devices and methods |
US20090299402A1 (en) * | 2005-11-14 | 2009-12-03 | Jms Co., Ltd. | Instrument for dilating blood channel and instrument for treating aortic dissection |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US9078781B2 (en) | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
US8075615B2 (en) | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US7846175B2 (en) * | 2006-04-03 | 2010-12-07 | Medrad, Inc. | Guidewire and collapsable filter system |
US7625403B2 (en) | 2006-04-04 | 2009-12-01 | Medtronic Vascular, Inc. | Valved conduit designed for subsequent catheter delivered valve therapy |
US7591848B2 (en) | 2006-04-06 | 2009-09-22 | Medtronic Vascular, Inc. | Riveted stent valve for percutaneous use |
US7524331B2 (en) | 2006-04-06 | 2009-04-28 | Medtronic Vascular, Inc. | Catheter delivered valve having a barrier to provide an enhanced seal |
US7740655B2 (en) | 2006-04-06 | 2010-06-22 | Medtronic Vascular, Inc. | Reinforced surgical conduit for implantation of a stented valve therein |
US7922684B2 (en) * | 2006-05-30 | 2011-04-12 | Boston Scientific Scimed, Inc. | Anti-obesity dual stent |
US20080234722A1 (en) * | 2006-06-14 | 2008-09-25 | Possis Medical, Inc. | Inferior vena cava filter on guidewire |
US9307995B2 (en) * | 2006-06-15 | 2016-04-12 | Cook Medical Technologies Llc | Methods, systems and devices for the delivery of endoluminal prostheses |
EP2572673B1 (en) | 2006-09-02 | 2015-08-19 | Boston Scientific Scimed, Inc. | Intestinal sleeves and associated deployment systems and methods |
US20100179583A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of deploying and retrieving an embolic diversion device |
WO2008033474A2 (en) | 2006-09-15 | 2008-03-20 | Synecor, Llc | System for anchoring stomach implant |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US8348996B2 (en) | 2006-09-19 | 2013-01-08 | Medtronic Ventor Technologies Ltd. | Valve prosthesis implantation techniques |
EP2083901B1 (en) | 2006-10-16 | 2017-12-27 | Medtronic Ventor Technologies Ltd. | Transapical delivery system with ventriculo-arterial overflow bypass |
US20080114440A1 (en) * | 2006-11-13 | 2008-05-15 | Sage Medical Technologies, Inc | Methods and devices for deploying an implant in curved anatomy |
US9107734B2 (en) * | 2006-11-29 | 2015-08-18 | Emboline, Inc. | Embolic protection device |
JP5593545B2 (en) | 2006-12-06 | 2014-09-24 | メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. | System and method for transapical delivery of a self-expanding valve secured to an annulus |
WO2008101193A2 (en) * | 2007-02-16 | 2008-08-21 | Emory University | Apparatus and methods for treating the aorta |
CA2677648C (en) | 2007-02-16 | 2015-10-27 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
ES2660667T3 (en) * | 2007-05-07 | 2018-03-23 | Protalix Ltd. | Large-scale disposable bioreactor |
US8216209B2 (en) | 2007-05-31 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US7867273B2 (en) | 2007-06-27 | 2011-01-11 | Abbott Laboratories | Endoprostheses for peripheral arteries and other body vessels |
US20090030284A1 (en) | 2007-07-18 | 2009-01-29 | David Cole | Overtube introducer for use in endoscopic bariatric surgery |
CN101827559B (en) | 2007-07-18 | 2013-05-29 | 压力感应器公司 | Endoscopic implant system |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8715337B2 (en) | 2007-11-09 | 2014-05-06 | Cook Medical Technologies Llc | Aortic valve stent graft |
DE102007056946A1 (en) * | 2007-11-27 | 2009-05-28 | Gunnar Pah | Device for filtering blood |
US8002816B2 (en) * | 2007-12-21 | 2011-08-23 | Cleveland Clinic Foundation | Prosthesis for implantation in aorta and method of using same |
US20090171383A1 (en) | 2007-12-31 | 2009-07-02 | David Cole | Gastric space occupier systems and methods of use |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
US8157853B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
WO2009094188A2 (en) | 2008-01-24 | 2009-07-30 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9089422B2 (en) | 2008-01-24 | 2015-07-28 | Medtronic, Inc. | Markers for prosthetic heart valves |
US8628566B2 (en) | 2008-01-24 | 2014-01-14 | Medtronic, Inc. | Stents for prosthetic heart valves |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
WO2009108355A1 (en) | 2008-02-28 | 2009-09-03 | Medtronic, Inc. | Prosthetic heart valve systems |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8020741B2 (en) | 2008-03-18 | 2011-09-20 | Barosense, Inc. | Endoscopic stapling devices and methods |
JP5391407B2 (en) * | 2008-04-03 | 2014-01-15 | クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニー | Self-cleaning device, system and method of use thereof |
US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
EP4119097A1 (en) | 2008-06-06 | 2023-01-18 | Edwards Lifesciences Corporation | Low profile transcatheter heart valve |
JP5762955B2 (en) | 2008-06-23 | 2015-08-12 | ルーメン・バイオメディカル・インコーポレイテッドLumen Biomedical, Inc. | Embolization prevention during percutaneous heart valve replacement and similar procedures |
US8845715B2 (en) * | 2008-08-18 | 2014-09-30 | Hisham M. F. SHERIF | Total aortic arch reconstruction graft |
US8998981B2 (en) | 2008-09-15 | 2015-04-07 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US8852225B2 (en) * | 2008-09-25 | 2014-10-07 | Medtronic, Inc. | Emboli guarding device |
JP5607639B2 (en) | 2008-10-10 | 2014-10-15 | サドラ メディカル インコーポレイテッド | Medical devices and systems |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
US7934631B2 (en) | 2008-11-10 | 2011-05-03 | Barosense, Inc. | Multi-fire stapling systems and methods for delivering arrays of staples |
EP2682072A1 (en) | 2008-12-23 | 2014-01-08 | Sorin Group Italia S.r.l. | Expandable prosthetic valve having anchoring appendages |
US9517148B2 (en) | 2009-04-16 | 2016-12-13 | Cvdevices, Llc | Devices, systems, and methods for the prevention of stroke |
US9636204B2 (en) | 2009-04-16 | 2017-05-02 | Cvdevices, Llc | Deflection devices, systems and methods for the prevention of stroke |
US9681967B2 (en) | 2009-04-16 | 2017-06-20 | Cvdevices, Llc | Linked deflection devices, systems and methods for the prevention of stroke |
US8512397B2 (en) | 2009-04-27 | 2013-08-20 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit |
US8961539B2 (en) | 2009-05-04 | 2015-02-24 | Boston Scientific Scimed, Inc. | Endoscopic implant system and method |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
US8500775B2 (en) * | 2009-12-02 | 2013-08-06 | Surefire Medical, Inc. | Protection device and method against embolization agent reflux |
US8696698B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
AU2011296361B2 (en) | 2010-09-01 | 2015-05-28 | Medtronic Vascular Galway | Prosthetic valve support structure |
EP2613737B2 (en) | 2010-09-10 | 2023-03-15 | Symetis SA | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
US20120116496A1 (en) | 2010-11-05 | 2012-05-10 | Chuter Timothy A | Stent structures for use with valve replacements |
US20120136431A1 (en) * | 2010-11-29 | 2012-05-31 | Wei-Hui Chen | Stent Graft System |
US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
RU2462197C1 (en) * | 2011-02-11 | 2012-09-27 | Общество с ограниченной ответственностью "АСТОР" | Method of active prophylaxis of acute cerebral circulation disorders of embologenic nature and filtering stent-graft for its realisation according to belyaev ov |
EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
ES2641902T3 (en) | 2011-02-14 | 2017-11-14 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
EP4119095A1 (en) | 2011-03-21 | 2023-01-18 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
CA2835893C (en) | 2011-07-12 | 2019-03-19 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
US8449565B2 (en) * | 2011-07-21 | 2013-05-28 | Francis Duhay | Approaches to venous occlusion for embolus management |
US9089668B2 (en) | 2011-09-28 | 2015-07-28 | Surefire Medical, Inc. | Flow directional infusion device |
US20130096606A1 (en) * | 2011-10-17 | 2013-04-18 | William C. Bruchman | Embolic protection devices and related systems and methods |
WO2013063124A1 (en) * | 2011-10-25 | 2013-05-02 | Boston Scientific Scimed, Inc. | Embolic debris deflector |
US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8636692B2 (en) * | 2011-11-16 | 2014-01-28 | Medtronic Ablation Frontiers Llc | Transseptal sheath with air bubble trap |
CN103126785A (en) * | 2011-11-28 | 2013-06-05 | 陈玮慧 | Modular scaffold vascular system |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
US9277993B2 (en) | 2011-12-20 | 2016-03-08 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
ES2523223T3 (en) | 2011-12-29 | 2014-11-24 | Sorin Group Italia S.R.L. | A kit for the implantation of prosthetic vascular ducts |
WO2013103979A1 (en) | 2012-01-06 | 2013-07-11 | Emboline, Inc. | Integrated embolic protection devices |
WO2013109623A1 (en) | 2012-01-17 | 2013-07-25 | Lumen Biomedical, Inc. | Aortic arch filtration system for carotid artery protection |
WO2013112547A1 (en) | 2012-01-25 | 2013-08-01 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
US9089341B2 (en) | 2012-02-28 | 2015-07-28 | Surefire Medical, Inc. | Renal nerve neuromodulation device |
ES2943709T3 (en) | 2012-04-06 | 2023-06-15 | Merlin Md Pte Ltd | Devices to treat an aneurysm |
WO2013154765A2 (en) | 2012-04-13 | 2013-10-17 | Regents Of The University Of Minnesota | Cardio-embolic stroke prevention |
US9888994B2 (en) | 2012-05-15 | 2018-02-13 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
WO2014032038A1 (en) * | 2012-08-24 | 2014-02-27 | Synecor Llc | System for facilitating transcatheter aortic valve procedures using femoral access |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US9629718B2 (en) | 2013-05-03 | 2017-04-25 | Medtronic, Inc. | Valve delivery tool |
EP2996630B1 (en) | 2013-05-14 | 2022-04-06 | Transverse Medical, Inc. | Catheter-based apparatuses |
CA2918220A1 (en) | 2013-07-17 | 2015-01-22 | Lake Region Manufacturing, Inc. | High flow embolic protection device |
US9561103B2 (en) | 2013-07-17 | 2017-02-07 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
GB2517169B (en) * | 2013-08-13 | 2015-07-01 | Cook Medical Technologies Llc | Double baffle vascular occluder |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
EP2859864A1 (en) | 2013-10-14 | 2015-04-15 | Protembis GmbH | Medical device for embolic protection |
US9889031B1 (en) | 2014-03-25 | 2018-02-13 | Surefire Medical, Inc. | Method of gastric artery embolization |
US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
PL3142598T3 (en) | 2014-05-16 | 2020-11-30 | Veosource Sa | Implantable self-cleaning blood filters |
JP6612854B2 (en) | 2014-09-14 | 2019-11-27 | エンボライン, インコーポレイテッド | Introducing sheath with embolic protection |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
EP3229736B1 (en) | 2014-12-09 | 2024-01-10 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and method of manufacture |
EP3653177B1 (en) * | 2015-01-11 | 2021-09-01 | Ascyrus Medical, LLC | Hybrid device for surgical aortic repair |
WO2016115375A1 (en) | 2015-01-16 | 2016-07-21 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
WO2016126524A1 (en) | 2015-02-03 | 2016-08-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having tubular seal |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
US20160287839A1 (en) | 2015-03-31 | 2016-10-06 | Surefire Medical, Inc. | Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
AU2016262564B2 (en) | 2015-05-14 | 2020-11-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
EP3294220B1 (en) | 2015-05-14 | 2023-12-06 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10335277B2 (en) | 2015-07-02 | 2019-07-02 | Boston Scientific Scimed Inc. | Adjustable nosecone |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10779940B2 (en) | 2015-09-03 | 2020-09-22 | Boston Scientific Scimed, Inc. | Medical device handle |
WO2017083437A1 (en) | 2015-11-09 | 2017-05-18 | Radiaction Ltd. | Radiation shielding apparatuses and applications thereof |
US10617509B2 (en) | 2015-12-29 | 2020-04-14 | Emboline, Inc. | Multi-access intraprocedural embolic protection device |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
US11331187B2 (en) | 2016-06-17 | 2022-05-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
US10780250B1 (en) | 2016-09-19 | 2020-09-22 | Surefire Medical, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US11400263B1 (en) | 2016-09-19 | 2022-08-02 | Trisalus Life Sciences, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US11197750B2 (en) | 2016-11-29 | 2021-12-14 | Lake Region Manufacturing, Inc. | Embolic protection device |
EP3570777A2 (en) | 2017-01-20 | 2019-11-27 | W. L. Gore & Associates, Inc. | Embolic filter system |
AU2018203053B2 (en) | 2017-01-23 | 2020-03-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CR20190381A (en) | 2017-01-23 | 2019-09-27 | Cephea Valve Tech Inc | Replacement mitral valves |
JP7094965B2 (en) | 2017-01-27 | 2022-07-04 | イエナバルブ テクノロジー インク | Heart valve imitation |
US10588636B2 (en) | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
EP3634311A1 (en) | 2017-06-08 | 2020-04-15 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
WO2019028161A1 (en) | 2017-08-01 | 2019-02-07 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
US10939996B2 (en) | 2017-08-16 | 2021-03-09 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
WO2019144071A1 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
EP3740160A2 (en) | 2018-01-19 | 2020-11-25 | Boston Scientific Scimed Inc. | Inductance mode deployment sensors for transcatheter valve system |
EP3749252A1 (en) | 2018-02-07 | 2020-12-16 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
EP3758651B1 (en) | 2018-02-26 | 2022-12-07 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
CN112399836A (en) | 2018-05-15 | 2021-02-23 | 波士顿科学国际有限公司 | Replacement heart valve commissure assemblies |
JP7109657B2 (en) | 2018-05-23 | 2022-07-29 | コーシム・ソチエタ・ア・レスポンサビリタ・リミタータ | heart valve prosthesis |
US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
US11338117B2 (en) | 2018-10-08 | 2022-05-24 | Trisalus Life Sciences, Inc. | Implantable dual pathway therapeutic agent delivery port |
WO2020123486A1 (en) | 2018-12-10 | 2020-06-18 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
EP3923861A4 (en) | 2019-02-13 | 2022-11-09 | Emboline, Inc. | Catheter with integrated embolic protection device |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
Citations (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4382445A (en) * | 1980-12-04 | 1983-05-10 | Cosmos Research Associates | Physiological fluid shunt system and improvements therefor |
US4794928A (en) * | 1987-06-10 | 1989-01-03 | Kletschka Harold D | Angioplasty device and method of using the same |
US4873978A (en) * | 1987-12-04 | 1989-10-17 | Robert Ginsburg | Device and method for emboli retrieval |
US4969896A (en) * | 1989-02-01 | 1990-11-13 | Interpore International | Vascular graft prosthesis and method of making the same |
US4986831A (en) * | 1988-04-25 | 1991-01-22 | Angeion Corporation | Medical implant |
US5053008A (en) * | 1990-11-21 | 1991-10-01 | Sandeep Bajaj | Intracardiac catheter |
US5375612A (en) * | 1992-04-07 | 1994-12-27 | B. Braun Celsa | Possibly absorbable blood filter |
US5443449A (en) * | 1991-03-01 | 1995-08-22 | Applied Medical Resources Corporation | Cholangiography catheter |
US5522881A (en) * | 1994-06-28 | 1996-06-04 | Meadox Medicals, Inc. | Implantable tubular prosthesis having integral cuffs |
US5545211A (en) * | 1993-09-27 | 1996-08-13 | Sooho Medi-Tech Co., Ltd. | Stent for expanding a lumen |
US5609628A (en) * | 1995-04-20 | 1997-03-11 | Keranen; Victor J. | Intravascular graft and catheter |
US5617878A (en) * | 1996-05-31 | 1997-04-08 | Taheri; Syde A. | Stent and method for treatment of aortic occlusive disease |
US5662671A (en) * | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US5674241A (en) * | 1995-02-22 | 1997-10-07 | Menlo Care, Inc. | Covered expanding mesh stent |
US5681345A (en) * | 1995-03-01 | 1997-10-28 | Scimed Life Systems, Inc. | Sleeve carrying stent |
US5683411A (en) * | 1994-04-06 | 1997-11-04 | William Cook Europe A/S | Medical article for implantation into the vascular system of a patient |
US5800525A (en) * | 1997-06-04 | 1998-09-01 | Vascular Science, Inc. | Blood filter |
US5814064A (en) * | 1997-03-06 | 1998-09-29 | Scimed Life Systems, Inc. | Distal protection device |
US5817100A (en) * | 1994-02-07 | 1998-10-06 | Kabushikikaisya Igaki Iryo Sekkei | Stent device and stent supplying system |
US5911734A (en) * | 1997-05-08 | 1999-06-15 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
US5919224A (en) * | 1997-02-12 | 1999-07-06 | Schneider (Usa) Inc | Medical device having a constricted region for occluding fluid flow in a body lumen |
US5951599A (en) * | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US6048331A (en) * | 1996-05-14 | 2000-04-11 | Embol-X, Inc. | Cardioplegia occluder |
US6066158A (en) * | 1996-07-25 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot encasing and removal wire |
US6139517A (en) * | 1997-12-15 | 2000-10-31 | Cardeon Corporation | Perfusion shunt apparatus and method |
US6254563B1 (en) * | 1997-12-15 | 2001-07-03 | Cardeon Corporation | Perfusion shunt apparatus and method |
US6361545B1 (en) * | 1997-09-26 | 2002-03-26 | Cardeon Corporation | Perfusion filter catheter |
US6616680B1 (en) * | 2000-11-01 | 2003-09-09 | Joseph M. Thielen | Distal protection and delivery system and method |
US6616682B2 (en) * | 2001-09-19 | 2003-09-09 | Jomed Gmbh | Methods and apparatus for distal protection during a medical procedure |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3417738C2 (en) | 1984-05-12 | 1986-10-02 | Ing. Walter Hengst GmbH & Co KG, 4400 Münster | Blood filter that can be used in veins |
FR2567405B1 (en) | 1984-07-12 | 1988-08-12 | Lefebvre Jean Marie | MEDICAL FILTER |
US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
BR9301980A (en) | 1993-06-09 | 1993-10-19 | Jose Pedro Da Dr Silva | INTRARTERIAL FILTER |
US5759170A (en) * | 1993-11-30 | 1998-06-02 | Heartport, Inc. | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US5989281A (en) * | 1995-11-07 | 1999-11-23 | Embol-X, Inc. | Cannula with associated filter and methods of use during cardiac surgery |
US6231544B1 (en) * | 1996-05-14 | 2001-05-15 | Embol-X, Inc. | Cardioplegia balloon cannula |
-
1997
- 1997-12-23 US US08/996,532 patent/US6258120B1/en not_active Expired - Lifetime
-
1998
- 1998-12-21 AU AU19374/99A patent/AU745809B2/en not_active Ceased
- 1998-12-21 CA CA2316237A patent/CA2316237C/en not_active Expired - Fee Related
- 1998-12-21 CA CA002650874A patent/CA2650874A1/en not_active Abandoned
- 1998-12-21 WO PCT/US1998/027215 patent/WO1999032050A1/en active IP Right Grant
- 1998-12-21 CA CA002647854A patent/CA2647854A1/en not_active Abandoned
- 1998-12-21 DE DE69839193T patent/DE69839193T2/en not_active Expired - Lifetime
- 1998-12-21 EP EP98964196A patent/EP1041940B1/en not_active Expired - Lifetime
- 1998-12-21 AT AT98964196T patent/ATE387153T1/en not_active IP Right Cessation
-
2000
- 2000-08-17 US US09/642,570 patent/US6499487B1/en not_active Expired - Lifetime
-
2002
- 2002-02-15 US US10/077,312 patent/US20020077596A1/en not_active Abandoned
Patent Citations (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4382445A (en) * | 1980-12-04 | 1983-05-10 | Cosmos Research Associates | Physiological fluid shunt system and improvements therefor |
US4794928A (en) * | 1987-06-10 | 1989-01-03 | Kletschka Harold D | Angioplasty device and method of using the same |
US4873978A (en) * | 1987-12-04 | 1989-10-17 | Robert Ginsburg | Device and method for emboli retrieval |
US4986831A (en) * | 1988-04-25 | 1991-01-22 | Angeion Corporation | Medical implant |
US4969896A (en) * | 1989-02-01 | 1990-11-13 | Interpore International | Vascular graft prosthesis and method of making the same |
US5053008A (en) * | 1990-11-21 | 1991-10-01 | Sandeep Bajaj | Intracardiac catheter |
US5443449A (en) * | 1991-03-01 | 1995-08-22 | Applied Medical Resources Corporation | Cholangiography catheter |
US5375612A (en) * | 1992-04-07 | 1994-12-27 | B. Braun Celsa | Possibly absorbable blood filter |
US5545211A (en) * | 1993-09-27 | 1996-08-13 | Sooho Medi-Tech Co., Ltd. | Stent for expanding a lumen |
US5817100A (en) * | 1994-02-07 | 1998-10-06 | Kabushikikaisya Igaki Iryo Sekkei | Stent device and stent supplying system |
US5683411A (en) * | 1994-04-06 | 1997-11-04 | William Cook Europe A/S | Medical article for implantation into the vascular system of a patient |
US5522881A (en) * | 1994-06-28 | 1996-06-04 | Meadox Medicals, Inc. | Implantable tubular prosthesis having integral cuffs |
US5674241A (en) * | 1995-02-22 | 1997-10-07 | Menlo Care, Inc. | Covered expanding mesh stent |
US5681345A (en) * | 1995-03-01 | 1997-10-28 | Scimed Life Systems, Inc. | Sleeve carrying stent |
US5609628A (en) * | 1995-04-20 | 1997-03-11 | Keranen; Victor J. | Intravascular graft and catheter |
US6048331A (en) * | 1996-05-14 | 2000-04-11 | Embol-X, Inc. | Cardioplegia occluder |
US5617878A (en) * | 1996-05-31 | 1997-04-08 | Taheri; Syde A. | Stent and method for treatment of aortic occlusive disease |
US5662671A (en) * | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US6066158A (en) * | 1996-07-25 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot encasing and removal wire |
US5919224A (en) * | 1997-02-12 | 1999-07-06 | Schneider (Usa) Inc | Medical device having a constricted region for occluding fluid flow in a body lumen |
US5814064A (en) * | 1997-03-06 | 1998-09-29 | Scimed Life Systems, Inc. | Distal protection device |
US5911734A (en) * | 1997-05-08 | 1999-06-15 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
US5800525A (en) * | 1997-06-04 | 1998-09-01 | Vascular Science, Inc. | Blood filter |
US5951599A (en) * | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US6361545B1 (en) * | 1997-09-26 | 2002-03-26 | Cardeon Corporation | Perfusion filter catheter |
US6139517A (en) * | 1997-12-15 | 2000-10-31 | Cardeon Corporation | Perfusion shunt apparatus and method |
US6254563B1 (en) * | 1997-12-15 | 2001-07-03 | Cardeon Corporation | Perfusion shunt apparatus and method |
US6616680B1 (en) * | 2000-11-01 | 2003-09-09 | Joseph M. Thielen | Distal protection and delivery system and method |
US6616682B2 (en) * | 2001-09-19 | 2003-09-09 | Jomed Gmbh | Methods and apparatus for distal protection during a medical procedure |
Cited By (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7192436B2 (en) * | 2001-11-08 | 2007-03-20 | Sub-Q, Inc. | Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US20050033360A1 (en) * | 2001-11-08 | 2005-02-10 | Sing Eduardo Chi | Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US10624732B2 (en) | 2001-12-05 | 2020-04-21 | Keystone Heart Ltd. | Endovascular device for entrapment of participate matter and method for use |
US9668849B2 (en) | 2001-12-05 | 2017-06-06 | Keystone Heart Ltd. | Endovascular device for entrapment of participate matter and method for use |
US7122043B2 (en) | 2003-05-19 | 2006-10-17 | Stout Medical Group, L.P. | Tissue distention device and related methods for therapeutic intervention |
US7648532B2 (en) | 2003-05-19 | 2010-01-19 | Septrx, Inc. | Tissue distention device and related methods for therapeutic intervention |
US8758395B2 (en) | 2003-05-19 | 2014-06-24 | Septrx, Inc. | Embolic filtering method and apparatus |
US20060178694A1 (en) * | 2003-05-19 | 2006-08-10 | Secant Medical, Llc | Tissue distention device and related methods for therapeutic intervention |
WO2005117717A1 (en) * | 2004-05-28 | 2005-12-15 | Sub-Q, Inc. | Pledget handling hemostasis system and method |
US8999364B2 (en) | 2004-06-15 | 2015-04-07 | Nanyang Technological University | Implantable article, method of forming same and method for reducing thrombogenicity |
US8795315B2 (en) | 2004-10-06 | 2014-08-05 | Cook Medical Technologies Llc | Emboli capturing device having a coil and method for capturing emboli |
US20060161241A1 (en) * | 2005-01-14 | 2006-07-20 | Denise Barbut | Methods and devices for treating aortic atheroma |
US8945169B2 (en) | 2005-03-15 | 2015-02-03 | Cook Medical Technologies Llc | Embolic protection device |
US8221446B2 (en) | 2005-03-15 | 2012-07-17 | Cook Medical Technologies | Embolic protection device |
US20060229660A1 (en) * | 2005-03-15 | 2006-10-12 | Dharmendra Pal | Embolic protection device |
US8109962B2 (en) | 2005-06-20 | 2012-02-07 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US8845677B2 (en) | 2005-06-20 | 2014-09-30 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US7850708B2 (en) | 2005-06-20 | 2010-12-14 | Cook Incorporated | Embolic protection device having a reticulated body with staggered struts |
US7867247B2 (en) | 2005-07-12 | 2011-01-11 | Cook Incorporated | Methods for embolic protection during treatment of a stenotic lesion in a body vessel |
US7766934B2 (en) | 2005-07-12 | 2010-08-03 | Cook Incorporated | Embolic protection device with an integral basket and bag |
US7771452B2 (en) | 2005-07-12 | 2010-08-10 | Cook Incorporated | Embolic protection device with a filter bag that disengages from a basket |
US8187298B2 (en) | 2005-08-04 | 2012-05-29 | Cook Medical Technologies Llc | Embolic protection device having inflatable frame |
US8377092B2 (en) | 2005-09-16 | 2013-02-19 | Cook Medical Technologies Llc | Embolic protection device |
US8632562B2 (en) | 2005-10-03 | 2014-01-21 | Cook Medical Technologies Llc | Embolic protection device |
US8182508B2 (en) | 2005-10-04 | 2012-05-22 | Cook Medical Technologies Llc | Embolic protection device |
US8252017B2 (en) | 2005-10-18 | 2012-08-28 | Cook Medical Technologies Llc | Invertible filter for embolic protection |
US8216269B2 (en) | 2005-11-02 | 2012-07-10 | Cook Medical Technologies Llc | Embolic protection device having reduced profile |
US8152831B2 (en) | 2005-11-17 | 2012-04-10 | Cook Medical Technologies Llc | Foam embolic protection device |
US20120165860A1 (en) * | 2006-05-08 | 2012-06-28 | S.M.T. Research & Development Ltd. | Device and method for vascular filter |
US8062324B2 (en) * | 2006-05-08 | 2011-11-22 | S.M.T. Research And Development Ltd. | Device and method for vascular filter |
US20070270901A1 (en) * | 2006-05-08 | 2007-11-22 | Shimon Dov V | Device and method for vascular filter |
US7727254B2 (en) | 2006-05-23 | 2010-06-01 | Pah Gunnar M | Method of removing heart valve stenosis |
US8758388B2 (en) | 2006-05-23 | 2014-06-24 | Gunnar M. Pah | Device for filtering of blood during removal of heart valve stenosis and method of removing heart valve stenosis |
US20100217175A1 (en) * | 2006-05-23 | 2010-08-26 | Pah Gunnar M | Device for Filtering of Blood During Removal of Heart Valve Stenosis and Method of Removing Heart Valve Stenosis |
US20090069841A1 (en) * | 2006-05-23 | 2009-03-12 | Pah Gunnar M | Device for Filtering of Blood During Removal of Heart Valve Stenosis and Method of Removing Heart Valve Stenosis |
US20080064957A1 (en) * | 2006-09-07 | 2008-03-13 | Spence Paul A | Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head |
US20110224582A1 (en) * | 2006-09-07 | 2011-09-15 | Spence Paul A | Methods related to diverting material in blood flow away from the head |
US20160317277A1 (en) * | 2006-09-11 | 2016-11-03 | Edwards Lifesciences Corporation | Embolic deflection device |
US9480548B2 (en) * | 2006-09-11 | 2016-11-01 | Edwards Lifesciences Ag | Embolic protection device and method of use |
US20100179585A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Embolic deflection device |
US20080065145A1 (en) * | 2006-09-11 | 2008-03-13 | Carpenter Judith T | Embolic protection device and method of use |
US8460335B2 (en) * | 2006-09-11 | 2013-06-11 | Embrella Cardiovascular, Inc. | Method of deflecting emboli from the cerebral circulation |
US10426591B2 (en) * | 2006-09-11 | 2019-10-01 | Edwards Lifesciences Ag | Embolic deflection device |
US20100179647A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure |
US20100211095A1 (en) * | 2006-09-11 | 2010-08-19 | Carpenter Judith T | Embolic Protection Device and Method of Use |
US9339367B2 (en) | 2006-09-11 | 2016-05-17 | Edwards Lifesciences Ag | Embolic deflection device |
US9907639B2 (en) | 2006-09-19 | 2018-03-06 | Cook Medical Technologies Llc | Apparatus and methods for in situ embolic protection |
US20080109055A1 (en) * | 2006-11-02 | 2008-05-08 | Sage Medical Technologies, Inc. | Implant for aortic dissection and methods of use |
US20080140110A1 (en) * | 2006-12-12 | 2008-06-12 | Spence Paul A | Implant, systems and methods for physically diverting material in blood flow away from the head |
US9901434B2 (en) | 2007-02-27 | 2018-02-27 | Cook Medical Technologies Llc | Embolic protection device including a Z-stent waist band |
US9138307B2 (en) | 2007-09-14 | 2015-09-22 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US8419748B2 (en) | 2007-09-14 | 2013-04-16 | Cook Medical Technologies Llc | Helical thrombus removal device |
US8252018B2 (en) | 2007-09-14 | 2012-08-28 | Cook Medical Technologies Llc | Helical embolic protection device |
US9398946B2 (en) | 2007-09-14 | 2016-07-26 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US9908143B2 (en) | 2008-06-20 | 2018-03-06 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
US11931484B2 (en) | 2008-06-20 | 2024-03-19 | Razmodics Llc | Composite stent having multi-axial flexibility and method of manufacture thereof |
US10893960B2 (en) | 2008-06-20 | 2021-01-19 | Razmodics Llc | Stent fabrication via tubular casting processes |
US10646359B2 (en) | 2008-06-20 | 2020-05-12 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
US10512468B2 (en) * | 2008-09-04 | 2019-12-24 | Swat Medical Ab | Temporary embolic protection device and medical procedure for delivery thereof |
US20140257367A1 (en) * | 2008-09-04 | 2014-09-11 | Swat Medical Ab | Temporary Embolic Protection Device And Medical Procedure For Delivery Thereof |
US9968359B2 (en) * | 2008-09-04 | 2018-05-15 | Swat Medical Ab | Temporary embolic protection device and medical procedure for delivery thereof |
US20140257368A1 (en) * | 2008-09-04 | 2014-09-11 | Swat Medical Ab | Temporary Embolic Protection Device And Medical Procedure For Delivery Thereof |
US8388644B2 (en) | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
US8657849B2 (en) | 2008-12-29 | 2014-02-25 | Cook Medical Technologies Llc | Embolic protection device and method of use |
US8372108B2 (en) | 2009-01-16 | 2013-02-12 | Claret Medical, Inc. | Intravascular blood filter |
US20100185231A1 (en) * | 2009-01-16 | 2010-07-22 | Lashinski Randall T | Intravascular Blood Filter |
US11284986B2 (en) | 2009-01-16 | 2022-03-29 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US10743977B2 (en) | 2009-01-16 | 2020-08-18 | Boston Scientific Scimed, Inc. | Intravascular blood filter |
US9326843B2 (en) | 2009-01-16 | 2016-05-03 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US11607301B2 (en) | 2009-01-16 | 2023-03-21 | Boston Scientific Scimed, Inc. | Intravascular blood filters and methods of use |
US9636205B2 (en) | 2009-01-16 | 2017-05-02 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US11364106B2 (en) | 2009-01-16 | 2022-06-21 | Boston Scientific Scimed, Inc. | Intravascular blood filter |
US20100191276A1 (en) * | 2009-01-29 | 2010-07-29 | Lashinski Randall T | Illuminated Intravascular Blood Filter |
US8518073B2 (en) | 2009-01-29 | 2013-08-27 | Claret Medical, Inc. | Illuminated intravascular blood filter |
US11191631B2 (en) | 2009-07-27 | 2021-12-07 | Boston Scientific Scimed, Inc. | Dual endovascular filter and methods of use |
US20110022076A1 (en) * | 2009-07-27 | 2011-01-27 | Lashinski Randall T | Dual Endovascular Filter and Methods of Use |
US8753370B2 (en) | 2009-07-27 | 2014-06-17 | Claret Medical, Inc. | Dual endovascular filter and methods of use |
US8974489B2 (en) | 2009-07-27 | 2015-03-10 | Claret Medical, Inc. | Dual endovascular filter and methods of use |
US10130458B2 (en) | 2009-07-27 | 2018-11-20 | Claret Medical, Inc. | Dual endovascular filter and methods of use |
US9345565B2 (en) | 2010-12-30 | 2016-05-24 | Claret Medical, Inc. | Steerable dual filter cerebral protection system |
US9492264B2 (en) | 2010-12-30 | 2016-11-15 | Claret Medical, Inc. | Embolic protection device for protecting the cerebral vasculature |
US10058411B2 (en) | 2010-12-30 | 2018-08-28 | Claret Madical, Inc. | Method of isolating the cerebral circulation during a cardiac procedure |
US9943395B2 (en) | 2010-12-30 | 2018-04-17 | Claret Medical, Inc. | Deflectable intravascular filter |
US9017364B2 (en) | 2010-12-30 | 2015-04-28 | Claret Medical, Inc. | Deflectable intravascular filter |
US9055997B2 (en) | 2010-12-30 | 2015-06-16 | Claret Medical, Inc. | Method of isolating the cerebral circulation during a cardiac procedure |
US8876796B2 (en) | 2010-12-30 | 2014-11-04 | Claret Medical, Inc. | Method of accessing the left common carotid artery |
US9259306B2 (en) | 2010-12-30 | 2016-02-16 | Claret Medical, Inc. | Aortic embolic protection device |
US9980805B2 (en) | 2010-12-30 | 2018-05-29 | Claret Medical, Inc. | Aortic embolic protection device |
US11141258B2 (en) | 2010-12-30 | 2021-10-12 | Claret Medical, Inc. | Method of isolating the cerebral circulation during a cardiac procedure |
US11213318B2 (en) | 2011-11-10 | 2022-01-04 | Medtronic Vascular, Inc. | Expandable introducer sheath and method |
US10959844B2 (en) | 2011-11-10 | 2021-03-30 | Medtronic, Inc. | System for deploying a device to a distal location across a diseased vessel |
US11751994B2 (en) | 2011-11-10 | 2023-09-12 | Medtronic, Inc. | System for deploying a device to a distal location across a diseased vessel |
US10729544B2 (en) | 2011-11-10 | 2020-08-04 | Medtronic, Inc. | System for deploying a device to a distal location across a diseased vessel |
US10874511B2 (en) | 2011-11-10 | 2020-12-29 | Medtronic, Inc. | System for deploying a device to a distal location across a diseased vessel |
US9370438B2 (en) | 2011-11-10 | 2016-06-21 | Transaortic Medical, Inc. | Method for deploying a device to a distal location across a diseased vessel |
US9545298B2 (en) | 2011-11-10 | 2017-01-17 | Transaortic Medical, Inc. | System for deploying a device to a distal location across a diseased vessel |
US11672564B2 (en) | 2011-11-10 | 2023-06-13 | Medtronic, Inc. | Expandable introducer sheath and method |
US11234845B2 (en) | 2013-05-17 | 2022-02-01 | Medtronic, Inc. | Expandable introducer sheath |
CN106102654A (en) * | 2014-01-10 | 2016-11-09 | 企斯动哈特有限公司 | Dissect independent deflector |
US20150297250A1 (en) * | 2014-04-16 | 2015-10-22 | Covidien Lp | Systems and methods for catheter advancement |
US10413309B2 (en) | 2014-04-16 | 2019-09-17 | Covidien Lp | Systems and methods for catheter advancement |
US10449028B2 (en) | 2015-04-22 | 2019-10-22 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
US9566144B2 (en) | 2015-04-22 | 2017-02-14 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
US20170182295A1 (en) * | 2015-12-28 | 2017-06-29 | Boston Scientific Scimed, Inc. | Medical devices with antithrombogenic coatings |
US10722690B2 (en) * | 2015-12-28 | 2020-07-28 | Boston Scientific Scimed, Inc. | Medical devices with antithrombogenic coatings |
US11337790B2 (en) | 2017-02-22 | 2022-05-24 | Boston Scientific Scimed, Inc. | Systems and methods for protecting the cerebral vasculature |
US20200268500A1 (en) * | 2017-09-28 | 2020-08-27 | Zeev Brandeis | Aortic protection |
US11191630B2 (en) | 2017-10-27 | 2021-12-07 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11154390B2 (en) | 2017-12-19 | 2021-10-26 | Claret Medical, Inc. | Systems for protection of the cerebral vasculature during a cardiac procedure |
US11439491B2 (en) | 2018-04-26 | 2022-09-13 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11351023B2 (en) | 2018-08-21 | 2022-06-07 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11559672B2 (en) | 2019-02-08 | 2023-01-24 | Nxt Biomedical, Llc | Left atrial appendage stasis reduction |
EP3921010A4 (en) * | 2019-02-08 | 2023-03-08 | NXT Biomedical, LLC | Left atrial appendage stasis reduction |
US11904120B2 (en) | 2019-02-08 | 2024-02-20 | Nxt Biomedical, Llc | Left atrial appendage stasis reduction |
US11382734B2 (en) | 2019-08-19 | 2022-07-12 | Encompass Technologies, Inc. | Embolic filter with controlled aperture size distribution |
US11707351B2 (en) | 2019-08-19 | 2023-07-25 | Encompass Technologies, Inc. | Embolic protection and access system |
CN110916851A (en) * | 2019-11-29 | 2020-03-27 | 复旦大学附属中山医院 | Universal heart valve intervention forming system |
WO2024042528A1 (en) * | 2022-08-25 | 2024-02-29 | Capricon Medical Ltd | Protecting coronary arteries and myocardium blood vessels during medical procedures |
Also Published As
Publication number | Publication date |
---|---|
CA2647854A1 (en) | 1999-07-01 |
DE69839193T2 (en) | 2009-02-26 |
EP1041940A1 (en) | 2000-10-11 |
ATE387153T1 (en) | 2008-03-15 |
CA2316237A1 (en) | 1999-07-01 |
WO1999032050A1 (en) | 1999-07-01 |
EP1041940B1 (en) | 2008-02-27 |
US6258120B1 (en) | 2001-07-10 |
EP1041940A4 (en) | 2001-08-22 |
US6499487B1 (en) | 2002-12-31 |
CA2650874A1 (en) | 1999-07-01 |
DE69839193D1 (en) | 2008-04-10 |
AU1937499A (en) | 1999-07-12 |
CA2316237C (en) | 2010-03-30 |
AU745809B2 (en) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6499487B1 (en) | Implantable cerebral protection device and methods of use | |
CA2254831C (en) | Aortic occluder with associated filter and methods of use during cardiac surgery | |
US6361545B1 (en) | Perfusion filter catheter | |
US6395014B1 (en) | Cerebral embolic protection assembly and associated methods | |
US6652555B1 (en) | Barrier device for covering the ostium of left atrial appendage | |
US10213288B2 (en) | Distal protection filter | |
US5769816A (en) | Cannula with associated filter | |
US6547760B1 (en) | Aortic catheter with porous aortic arch balloon and methods for selective aortic perfusion | |
JP4318880B2 (en) | Blood vessel filter | |
WO1997042879A9 (en) | Aortic occluder with associated filter and methods of use during cardiac surgery | |
US20060253148A1 (en) | Apparatus and method of using an occluder for embolic protection | |
WO2002056955A1 (en) | Arterial cannula with perforated filter lumen | |
US9962252B2 (en) | Aortic great vessel protection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EDWARDS LIFESCIENCES CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EMBOL-X, INC.;REEL/FRAME:013998/0632 Effective date: 20030417 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |